You are an MBBS 1st year Physiology professor. Analyze all the files I upload (syllabus, paper pattern, and previous year question papers). Tasks: 1. Identify the complete syllabus covered. 2. Analyze the paper pattern: - Marks distribution - Question types (LAQ, SAQ, Short Notes, Give Reasoning, Viva-style, MCQs if any) - Frequently repeated topics - High-yield and low-yield topics - Topics asked in multiple ways 3. Categorize every topic into: - Must Know (Very High Yield) - High Yield - Moderate Yield - Low Yield 4. Predict all probable questions that can appear in the next exam based on PYQ trends. 5. Extract every question from all previous papers without missing any and organize them topic-wise. Remove duplicates but mention how many times each question has appeared. 6. Create a master question bank grouped by topic and marks (10M, 5M, 3M, 2M, viva, reasoning, clinical, diagrams). 7. Mention all important diagrams, flowcharts, tables, and clinical correlations expected from each topic. (Just mention diagram dont generate images) 8. Do not answer the questions yet. Only prepare the complete analysis and structured roadmap.
cd /tmp/workspace/attachments/2c1918e0-7341-4d95-9e2a-0ad630a8b649 && python3 -c " import pdfplumber with pdfplumber.open('physio pyq.pdf') as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): text = page.extract_text() print(f'\\n===PAGE {i+1}===') print(text) " 2>&1 | head -500
cd /tmp/workspace/attachments/2c1918e0-7341-4d95-9e2a-0ad630a8b649 && python3 -c " import pdfplumber with pdfplumber.open('physio pyq.pdf') as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages[7:], start=8): text = page.extract_text() print(f'\\n===PAGE {i}===') print(text) " 2>&1
| # | System/Topic |
|---|---|
| 1 | Cardiovascular System (CVS) |
| 2 | Respiratory System |
| 3 | Endocrine System |
| 4 | Reproductive System |
| 5 | Gastrointestinal Tract (GIT) |
| 6 | Environmental Physiology |
| 7 | Temperature Regulation |
| 8 | Exercise Physiology |
| 9 | AETCOM (Attitude, Ethics & Communication Module) |
| Section | Question Type | Marks | Choice |
|---|---|---|---|
| Section A | MCQ (Multiple Choice) | 20 x 1 = 20 | No choice (all compulsory) |
| Section B | SAQ (Short Answer) | 4 x 5 = 20 | Any 4 out of 5 |
| Section B | LAQ (Long Answer) | 2 x 10 = 20 | Any 2 out of 3 |
| Section C | SAQ (Short Answer) | 4 x 5 = 20 | Any 4 out of 5 |
| Section C | LAQ (Long Answer) | 2 x 10 = 20 | Any 2 out of 3 |
| TOTAL | 100 |
| Section | Systems Covered |
|---|---|
| Section A (MCQ) | Mixed - all systems, CVS and Respiratory dominant |
| Section B | CVS + Respiratory |
| Section C | Endocrine + Reproductive + GIT + Env. Physiology + Temp Regulation |
| Question Type | Description | Marks |
|---|---|---|
| LAQ | Long Answer Questions - detailed essays with sub-parts | 10 marks |
| SAQ | Short Answer Questions | 5 marks |
| Clinical Vignette SAQ | Patient-based scenario with 3-4 sub-questions | 5 marks |
| MCQ | Single best answer (4 options) | 1 mark each |
| Diagram-based | Draw and label diagrams | Part of LAQ/SAQ |
| Give Reasoning | Explain physiological basis of clinical findings | Sub-part of clinical SAQ |
| Calculation-based | Numerical (cardiac output, cardiac index, FEV1 interpretation) | Sub-part of SAQ |
| Q# | Question | Appeared (Times) |
|---|---|---|
| CVS-L1 | Describe pressure and volume changes in the ventricles during the cardiac cycle with the help of a diagram. | 2x (Nov 2021, 2022-23 Prelim) |
| CVS-L2 | Explain the regulation of cardiac output. Describe in brief any one method to measure cardiac output. (2+5+3) | 2x (seen in 2 papers) |
| CVS-L3 | Define blood pressure. Enlist mechanisms regulating arterial blood pressure. Describe the baroreceptor mechanism in detail. (1+3+6) | 3x (Nov 2021 Sec B, 2019, 2022 Prelim area) |
| CVS-L4 | Describe the role of baroreceptors in regulation of blood pressure. | 2x |
| CVS-L5 | Describe cardiorespiratory changes during moderate exercise. | 2x (seen in multiple papers) |
| Q# | Question | Appeared (Times) |
|---|---|---|
| CVS-S1 | Draw and label a neat diagram of ECG. Describe the waves and intervals. | 2x |
| CVS-S2 | Describe compensatory mechanisms for hypovolaemic shock. | 2x (Nov 2020, Prelim 2023) |
| CVS-S3 | An adult person has: EDV = 130 ml, ESV = 80 ml, HR = 70/min, Surface area = 1.7 sq.m. (i) Calculate cardiac output. (ii) Calculate cardiac index. (iii) Give opinion on findings. | 1x (Prelim 2023) |
| CVS-S4 | Milk ejection reflex for measurement of cardiac output (Fick's principle context) | 1x |
| CVS-S5 | Write a note on Progressive shock. | 1x (2019) |
| Q# | Scenario | Appeared (Times) |
|---|---|---|
| CVS-C1 | Patient with sudden breathlessness, chronic smoker, FEV1 = 60% (spirometry). (i) Condition? (ii) What is FEV1? (iii) Normal value? - Note: This actually tests Respiratory, linked to CVS context. | 1x (Prelim 2023) |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-CVS1 | ECG lead connections (Lead I: Rt arm +ve, Lt arm -ve) | 2x |
| MCQ-CVS2 | Cardiac output increased in: Beriberi / AV fistula / Hyperthyroidism (All of these) | 2x |
| MCQ-CVS3 | Normal mean electrical axis (mean QRS vector): +59 degrees | 2x |
| MCQ-CVS4 | Average oxygen utilization of myocardium per 100g/min at rest: 8-10 ml | 1x |
| MCQ-CVS5 | Preload of heart is determined by: End diastolic volume | 2x |
| MCQ-CVS6 | ECG connections for Lead I | 2x |
| MCQ-CVS7 | Hormone produced by placenta: Human Chorionic Somatomammotropin (HCS) | 1x (though reproductive, appears in CVS MCQ area) |
| MCQ-CVS8 | Laminar blood flow - true statement | 1x |
| MCQ-CVS9 | Cardiogenic vs Distributive shock | 1x |
| MCQ-CVS10 | Bitemporal hemianopia - right optic nerve / optic chiasma | 1x |
| MCQ-CVS11 | Sympathetic nerve supply - internal sphincter | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Resp-L1 | Describe different steps in transport of oxygen. Define Bohr Effect. Discuss oxygen-hemoglobin dissociation curve with factors affecting it. Add a note on P50. (2+1+4+3) | 2x (Nov 2021, and another paper) |
| Resp-L2 | What is hypoxia? Classify hypoxia. Explain effects of hypoxia on body. (2+4+4) | 2x (Prelim 2023, 2021) |
| Resp-L3 | Describe cardiorespiratory changes during moderate exercise. | 2x |
| Resp-L4 | Describe the mechanisms of regulation of respiration. | 1x (2019) |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Resp-S1 | Define Dead Space and describe its types. | 2x (Prelim 2023, 2021) |
| Resp-S2 | A patient presents with FEV1/FVC = 35%, PEFR = 150 L/min (normal 450). (i) Diagnosis? (ii) Explain findings. (iii) Physiological basis of treatment. | 2x |
| Resp-S3 | Hyperbaric oxygen therapy is useful in: Gas gangrene / CO poisoning / Anaerobic infections. Explain. | 1x (Nov 2020) |
| Resp-S4 | Carbon monoxide poisoning - physiological explanation. | 1x (Nov 2020) |
| Resp-S5 | What is decompression sickness? What gas is responsible? | 1x |
| Resp-S6 | A patient with chronic cough, breathlessness, chronic smoker, FEV1 = 60%. What is condition? FEV1 value meaning? Normal value? | 2x (Prelim 2023 appears twice) |
| Q# | Scenario | Appeared (Times) |
|---|---|---|
| Resp-C1 | Spirometry finding: FEV1 = 35%, FVC near normal. (i) Condition? (ii) FEV1 meaning? (iii) Physiological basis of treatment. | 2x |
| Resp-C2 | Patient with breathlessness exposed to 150 L/min flow rate PEFR. Identify condition, physiological basis of treatment. | 1x |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-R1 | O2-Hb dissociation curve shifts to LEFT in presence of all EXCEPT: Exercise (answer: Exercise shifts right) | 3x |
| MCQ-R2 | Hering-Breuer reflex abolished by vagotomy | 2x |
| MCQ-R3 | Gas responsible for decompression sickness: Nitrogen | 2x |
| MCQ-R4 | Cyanosis manifests when deoxygenated Hb > 5 gm% | 2x |
| MCQ-R5 | FEV1 interpretation / FEV1/FVC ratio | 2x |
| MCQ-R6 | Number of layers in respiratory membrane: 6 | 1x |
| MCQ-R7 | Head rotation in semicircular canal | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Endo-L1 | Name hormones secreted by thyroid gland. What are the actions of thyroid hormones on cardiovascular and CNS? Enlist features of Hyperthyroidism. (2+4+4) | 3x (Nov 2021, Dec 2022, repeated) |
| Endo-L2 | Name the hormones secreted by adrenal cortex. Describe actions of glucocorticoids in detail. Add a note on Cushing's syndrome. (3+4+3) | 3x (Nov 2021 Sec B, another paper) |
| Endo-L3 | List hormones secreted by anterior and posterior pituitary. Describe actions of one hormone from each. | 1x (2023 Prelim context) |
| Endo-L4 | Name the hormones secreted by islets of Langerhans. Explain synthesis and secretion of insulin with its effects. Describe effects of insulin with physiological basis of Diabetes mellitus. (2+3+5) | 2x |
| Endo-L5 | Describe the metabolism of calcium and its regulation. Explain effects of excess aldosterone secretion on body. (3+5+2) | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Endo-S1 | Cushing's syndrome - features and physiological basis. | 3x (Nov 2021, as part of LAQ and SAQ) |
| Endo-S2 | Describe clinical features of tetany and give its physiological basis. | 2x |
| Endo-S3 | Upper extremity - adenoma of adrenal gland - develop symptoms. What are symptoms? Single reason for development? Single investigation to help in diagnosis? | 1x (Nov 2021 clinical) |
| Q# | Scenario | Appeared (Times) |
|---|---|---|
| Endo-C1 | A 35-year-old female with swelling of face/limbs, intolerance to cold, tiredness, weight gain, hoarseness of voice, excessive sleepiness. Tongue enlarged, ankle jerk slow, skin pale and thick, non-pitting oedema. (i) What is condition? (ii) Explain non-pitting oedema. (iii) Treatment. | 3x (Nov 2021, 2022-23 Prelim) |
| Endo-C2 | Patient with tremors of hands, intolerance to heat, muscle weakness. (i) Probable cause? (ii) Suggest investigations. (iii) Physiological basis of treatment. | 2x (2022-23 Prelim) |
| Endo-C3 | A patient presented with features of Cushing's syndrome after chronic steroid use. Reason for development? Investigation? Adrenalectomy effects? | 1x |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-E1 | Hypothyroidism features: intolerance to COLD (NOT heat), constipation, increased sleeping | 3x |
| MCQ-E2 | A patient with hypothyroidism likely to have: Intolerance to cold | 3x |
| MCQ-E3 | Estrogen acts on: Cytoplasmic receptors (nuclear/intracellular receptors) | 2x |
| MCQ-E4 | Somatomedin mediates: Deposition of chondroitin sulphate in bone for epiphyseal growth | 2x |
| MCQ-E5 | Oral contraceptive mechanism: Prevention of ovulation of Graafian follicles (main mechanism) | 2x |
| MCQ-E6 | Ejection hormone produced after delivery: Oxytocin | 1x |
| MCQ-E7 | Somatomedin deficiency: Laron dwarfism | 1x |
| MCQ-E8 | Hypothyroidism characterized by: Decreased BMR | 1x |
| MCQ-E9 | Growth hormone acts via: Somatomedins (IGF-1) | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Repro-L1 | What is spermatogenesis? Describe the process. Add a note on effects of removal of testes after puberty. (1+5+4) | 2x (Nov 2021, 2022-23 area) |
| Repro-L2 | Define menstrual cycle. Describe phases of menstrual cycle. Add a note on tests to detect ovulation. (2+5+3) | 2x (Nov 2021, another paper) |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Repro-S1 | Describe physiological basis of oral contraceptives. OR Mechanism of oral contraceptives. | 2x |
| Repro-S2 | What is milk ejection reflex? What is its pathway? | 1x |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-Rep1 | Time of ovulation: 14 days BEFORE menstruation / 18 days AFTER onset of menstruation | 3x |
| MCQ-Rep2 | Mechanism of oral contraceptive - prevention of ovulation of Graafian follicle | 2x |
| MCQ-Rep3 | Human Chorionic Somatomammotropin (HCS) produced by: Placenta | 1x |
| MCQ-Rep4 | Hormone responsible for implantation: Progesterone | 1x |
| MCQ-Rep5 | Vasectomy: Blocks passage of sperms | 1x |
| MCQ-Rep6 | FSH and LH - Gonadotrophs (anterior pituitary) | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| GIT-L1 | Describe composition and functions of gastric juice. Discuss synthesis of pepsin. Add a note on Acid-Peptic disease. (2+2+3+3) | 2x (Nov 2021 Sec B, 2022-23) |
| GIT-L2 | What is deglutition (swallowing)? What are its stages? Describe the second stage of deglutition. (1+2+4+3) | 2x (Nov 2021) |
| Q# | Question | Appeared (Times) |
|---|---|---|
| GIT-S1 | Describe movements of small intestine. | 3x (Nov 2021, Prelim 2023) |
| GIT-S2 | Write a note on Bile. Describe composition and functions of bile. | 1x |
| Q# | Scenario | Appeared (Times) |
|---|---|---|
| GIT-C1 | Patient with yellowish discoloration of sclera and skin. Stools clay-coloured, bulky, foul-smelling. Investigations: Stool - Stercobilinogen absent; Urine - Bilirubin present, Bile salts present; Blood - Serum albumin lowered, Serum bilirubin 6 mg/100 ml. (i) Diagnosis? (ii) Why stools pale and bulky? (iii) Why Van den Bergh test direct positive? | 2x (Nov 2021 Sec B clinical) |
| GIT-C2 | Patient with history suggesting malabsorption / obstructive jaundice / hepatic disorder - explain stool changes, bilirubin metabolism. | 1x |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-GIT1 | Stimulation of parasympathetic nerves of GIT produces: Increase in motility | 2x |
| MCQ-GIT2 | Phase of swallowing that is involuntary: Pharyngeal & Oesophageal phases | 2x |
| MCQ-GIT3 | CCK secretion stimulated by: Protein digestion products / Fat | 2x |
| MCQ-GIT4 | Acid stimulus causes: Secretin release | 1x |
| MCQ-GIT5 | Glycine is a: Neurotransmitter (inhibitory) | 1x |
| MCQ-GIT6 | Saliva - enzyme content / ptyalin | 1x |
| MCQ-GIT7 | Bile - role in digestion | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Temp-S1 | What is normal body temperature? Explain role of hypothalamus in temperature regulation. | 2x |
| Temp-S2 | What is temperature regulation? Give its physiological basis. How is it measured? | 2x (2022-23 Prelim area) |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-T1 | Normal body temperature (37°C / 98.6°F) | 2x |
| MCQ-T2 | Hypothalamus role in temperature regulation - set point | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Env-S1 | Hyperbaric oxygen therapy - uses and physiological basis. | 2x |
| Env-S2 | Carbon monoxide poisoning - physiological explanation. | 2x |
| Env-S3 | Decompression sickness - gas responsible and mechanism. | 2x |
| Env-S4 | High altitude physiology - acclimatization changes. | 2x (2019, 2022) |
| Q# | MCQ Topic | Appeared (Times) |
|---|---|---|
| MCQ-Env1 | Gas responsible for decompression sickness: Nitrogen | 2x |
| MCQ-Env2 | Hyperbaric O2 therapy useful in: Gas gangrene, CO poisoning | 2x |
| MCQ-Env3 | High altitude - compensatory changes | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| Exer-L1 | Describe cardiorespiratory changes during moderate exercise. | 3x (Multiple papers) |
| Exer-S1 | What are the changes in vital capacity, tidal volume, etc. during exercise? | 1x |
| Q# | Question | Appeared (Times) |
|---|---|---|
| AETCOM-1 | Doctor-Patient relationship. | 2x (Nov 2021 Sec B and C) |
| AETCOM-2 | Phantom limb phenomenon - physiological and psychological basis. | 1x |
| # | Topic | System | Why Critical |
|---|---|---|---|
| 1 | Cardiac cycle - pressure & volume changes | CVS | LAQ every paper |
| 2 | Regulation of cardiac output + measurement (Fick's principle) | CVS | LAQ every paper |
| 3 | Baroreceptor mechanism / Arterial BP regulation | CVS | LAQ 3x |
| 4 | O2-Hb dissociation curve + Bohr effect + P50 | Respiratory | LAQ 3x |
| 5 | Oxygen transport | Respiratory | LAQ 3x |
| 6 | Thyroid hormones - actions on CVS and CNS + Hyperthyroidism | Endocrine | LAQ 3x |
| 7 | Hypothyroidism - clinical features + physiology (myxoedema) | Endocrine | Clinical SAQ 3x |
| 8 | Glucocorticoids - actions + Cushing's syndrome | Endocrine | LAQ 3x |
| 9 | Movements of small intestine | GIT | SAQ 3x |
| 10 | Spermatogenesis + effects of castration | Reproductive | LAQ 2x |
| 11 | Menstrual cycle - phases + ovulation detection | Reproductive | LAQ 2x |
| 12 | Cardiorespiratory changes during exercise | Exercise Physio | LAQ 3x |
| 13 | FEV1/FVC - COPD / Obstructive lung disease clinical scenario | Respiratory | Clinical SAQ 3x |
| 14 | Hypovolaemic shock - compensatory mechanisms | CVS | SAQ 2x |
| # | Topic | System |
|---|---|---|
| 1 | Deglutition (swallowing) - stages, second stage detail | GIT |
| 2 | Gastric juice - composition, functions, pepsin synthesis, acid-peptic disease | GIT |
| 3 | Hypoxia - classification, effects | Respiratory |
| 4 | Dead space - types | Respiratory |
| 5 | Temperature regulation - hypothalamus role | Temp Regulation |
| 6 | Hyperbaric O2 therapy + CO poisoning | Environmental |
| 7 | Decompression sickness | Environmental |
| 8 | Oral contraceptives - mechanism | Reproductive |
| 9 | Obstructive jaundice - Van den Bergh test, bilirubin metabolism | GIT |
| 10 | ECG - waves, intervals, diagram | CVS |
| 11 | Cardiac output calculation (numerical) | CVS |
| 12 | Insulin - synthesis, secretion, effects, Diabetes mellitus | Endocrine |
| 13 | Tetany - clinical features and physiological basis | Endocrine |
| 14 | Pituitary hormones - anterior and posterior | Endocrine |
| 15 | High altitude acclimatization | Environmental |
| # | Topic | System |
|---|---|---|
| 1 | Progressive shock classification | CVS |
| 2 | Laminar vs turbulent blood flow | CVS |
| 3 | Hering-Breuer reflex | Respiratory |
| 4 | Respiratory membrane structure | Respiratory |
| 5 | Aldosterone - actions, excess effects | Endocrine |
| 6 | Calcium metabolism and regulation (PTH, Vit D) | Endocrine |
| 7 | Bile - composition, functions | GIT |
| 8 | Milk ejection reflex (oxytocin pathway) | Reproductive |
| 9 | Doctor-Patient relationship (AETCOM) | AETCOM |
| 10 | Phantom limb phenomenon | AETCOM/Neuro |
| # | Topic | System |
|---|---|---|
| 1 | Semicircular canal - head rotation | Neuro/Special senses |
| 2 | Bitemporal hemianopia (optic chiasma) | Neuro |
| 3 | Glycine as inhibitory neurotransmitter | Neuro |
| 4 | Salivary digestion details | GIT |
| 5 | Vasectomy mechanism | Reproductive |
| 6 | HCS (Human Chorionic Somatomammotropin) | Reproductive |
| Rank | Topic | Times Repeated | Question Types |
|---|---|---|---|
| 1 | Cardiac cycle pressure-volume changes | 3 | LAQ, MCQ |
| 2 | Thyroid hormones + Hyperthyroidism | 3 | LAQ, Clinical SAQ, MCQ |
| 3 | Glucocorticoids + Cushing's syndrome | 3 | LAQ, SAQ |
| 4 | Cardiorespiratory changes in exercise | 3 | LAQ |
| 5 | O2-Hb dissociation curve + Bohr effect | 3 | LAQ, MCQ |
| 6 | FEV1 / Obstructive lung disease | 3 | Clinical SAQ, MCQ |
| 7 | Hypothyroidism clinical vignette | 3 | Clinical SAQ, MCQ |
| 8 | Movements of small intestine | 3 | SAQ |
| 9 | Baroreceptor mechanism / BP regulation | 3 | LAQ |
| 10 | Menstrual cycle / Spermatogenesis | 2 | LAQ |
| Topic | Ways it has been asked |
|---|---|
| Thyroid hormones | (a) Actions on CVS+CNS, (b) Features of hyperthyroidism, (c) Clinical vignette - patient with tremors/heat intolerance, (d) MCQ: hypothyroid features, (e) MCQ: intolerance to cold |
| Cardiac output | (a) LAQ - regulation, (b) SAQ - measurement (Fick's principle), (c) Numerical calculation - cardiac output + cardiac index, (d) MCQ - CO increased in which conditions |
| Oxygen transport | (a) Steps in O2 transport, (b) O2-Hb dissociation curve, (c) Bohr effect, (d) P50, (e) MCQ - shifts of curve, (f) Cyanosis MCQ |
| Shock | (a) Hypovolaemic shock compensatory mechanisms, (b) Progressive shock, (c) Cardiogenic vs distributive MCQ |
| FEV1/Spirometry | (a) Define FEV1, (b) Clinical scenario - COPD, (c) FEV1 = 35% - obstructive pattern, (d) Normal FEV1 value MCQ |
| Cushing's syndrome | (a) As note in glucocorticoid LAQ, (b) Standalone SAQ, (c) Clinical vignette - adrenal adenoma scenario |
| Oral contraceptives | (a) Mechanism MCQ, (b) Physiological basis SAQ |
| Temperature | (a) Normal body temp MCQ, (b) Hypothalamus role SAQ, (c) Clinical - set point concept |
| GIT hormones | (a) CCK - stimulus MCQ, (b) Secretin - acid stimulus MCQ, (c) Parasympathetic effects on GIT MCQ |
| # | Likely MCQ | System |
|---|---|---|
| 1 | Normal mean QRS axis | CVS |
| 2 | ECG Lead I connections | CVS |
| 3 | Preload determined by | CVS |
| 4 | Cardiac output increased in (Beriberi/AV fistula/Hyperthyroidism) | CVS |
| 5 | O2-Hb curve shifts LEFT in | Respiratory |
| 6 | Cyanosis - threshold of deoxygenated Hb | Respiratory |
| 7 | Hering-Breuer reflex abolished by | Respiratory |
| 8 | Hypothyroidism feature - cold intolerance | Endocrine |
| 9 | Time of ovulation (14 days before menstruation) | Reproductive |
| 10 | Estrogen receptor type - cytoplasmic/nuclear | Endocrine |
| 11 | Oral contraceptive - main mechanism | Reproductive |
| 12 | Parasympathetic effect on GIT | GIT |
| 13 | Phase of swallowing that is involuntary | GIT |
| 14 | CCK stimulus | GIT |
| 15 | Gas causing decompression sickness | Env. Physio |
| 16 | Somatomedin - function / Laron dwarfism | Endocrine |
| 17 | Normal body temperature | Temp Regulation |
| 18 | FEV1/FVC normal value | Respiratory |
| 19 | Laminar blood flow property | CVS |
| 20 | Vasectomy - mechanism | Reproductive |
| Priority | What to Focus | Time Allocation |
|---|---|---|
| Week 1 | CVS (Cardiac cycle, Cardiac output, BP regulation, ECG, Shock) | 25% |
| Week 2 | Respiratory (O2 transport, Hb curve, Hypoxia, Dead space, Environmental) | 25% |
| Week 3 | Endocrine (Thyroid, Adrenal, Insulin/DM, Pituitary, Calcium) | 25% |
| Week 4 | GIT (Swallowing, Gastric juice, Small intestine, Bilirubin) + Reproductive (Spermatogenesis, Menstrual cycle) + AETCOM + Temp Regulation | 25% |
| Throughout | MCQs - 20 daily from all systems | Parallel |
Using the analysis you already created, teach me the entire Physiology Paper 1 syllabus. Instructions: 1. Cover one topic at a time. 2. Use standard MBBS textbooks ( V.D Joshi,Guyton,AK Jain) 3. For every topic include: - Concept explained from basics to exam level - Important definitions - Mechanisms and flowcharts - Diagrams (describe what to draw no need of image generation) - Clinical correlations - Give Reasoning questions with answers - Short Notes - Long Essay (10 marks) - Short Essay (5 marks) - MCQs if relevant 4. Solve every previous year question completely. Integrate those questions into the topic instead of answering them separately. 5. Also include all probable new questions that have not yet appeared but are likely to be asked. 6. Present answers exactly as expected in MBBS university exams with headings, subheadings, tables, mnemonics, and examiner-friendly formatting. 7. Finish one topic completely before moving to the next.
The cardiac cycle is the sequence of mechanical and electrical events that repeats with every heartbeat - from the beginning of one heartbeat to the beginning of the next. (Guyton & Hall, Ch. 9)
| Valve | Location | Type | Opens When | Closes When |
|---|---|---|---|---|
| Mitral (Bicuspid) | Left AV | AV valve | LV pressure < LA pressure | LV pressure > LA pressure |
| Tricuspid | Right AV | AV valve | RV pressure < RA pressure | RV pressure > RA pressure |
| Aortic | Left outflow | Semilunar | LV pressure > Aortic pressure | LV pressure < Aortic pressure |
| Pulmonary | Right outflow | Semilunar | RV pressure > Pulmonary pressure | RV pressure < Pulmonary pressure |
Key rule: All cardiac valves open and close PASSIVELY based on pressure gradients. There is NO muscular control of valves.
| Phase | Both Valves State | What Happens |
|---|---|---|
| 1. Ventricular Filling (Diastole) | AV open, Semilunar closed | Blood fills ventricle |
| 2. Isovolumetric Contraction (Systole) | BOTH CLOSED | Ventricle contracts, no volume change |
| 3. Ventricular Ejection (Systole) | AV closed, Semilunar open | Blood ejected into aorta/pulmonary artery |
| 4. Isovolumetric Relaxation (Diastole) | BOTH CLOSED | Ventricle relaxes, no volume change |
Mnemonic for atrial kick: "A for Atria, A for Add 25%" - Atria add the final 25% of ventricular filling
Key exam point: IVC is the phase with HIGHEST myocardial oxygen consumption per unit time because all energy goes into pressure development, not shortening.
Stroke Volume = EDV - ESV = 130 - 50 = 80 ml (at rest)
| Phase | LV Pressure | Aortic Pressure | LV Volume | Mitral Valve | Aortic Valve |
|---|---|---|---|---|---|
| Atrial Systole | ~0 → 8 mmHg | 80 mmHg (diastolic) | 120 → 130 ml | OPEN | Closed |
| IVC | 8 → 80 mmHg | 80 mmHg | 130 ml (no change) | Closed | Closed |
| Rapid Ejection | 80 → 120 mmHg | 80 → 120 mmHg | 130 → 80 ml | Closed | OPEN |
| Slow Ejection | 120 → 100 mmHg | 120 → 100 mmHg | 80 → 50 ml | Closed | OPEN |
| IVR | 100 → 0 mmHg | 100 → 80 mmHg | 50 ml (no change) | Closed | Closed |
| Rapid Filling | 0 → -2 mmHg | 80 mmHg | 50 → 110 ml | OPEN | Closed |
| Slow Filling | ~0 mmHg | 80 mmHg | 110 → 120 ml | OPEN | Closed |
| Parameter | Value | Significance |
|---|---|---|
| End Diastolic Volume (EDV) | 120-130 ml | = Preload; maximum volume in ventricle |
| End Systolic Volume (ESV) | 40-50 ml | Residual volume after ejection |
| Stroke Volume (SV) | 70-80 ml | EDV - ESV; blood ejected per beat |
| Ejection Fraction (EF) | 60-65% | SV/EDV × 100; index of ventricular function |
| Cardiac Output (CO) | 5 L/min | SV × HR; total blood pumped per minute |
| Cardiac Reserve | 3-4x resting CO | Can increase during exercise |
Exam-important: Normal ejection fraction = 60-65%. In heart failure it falls below 40%.
| Sound | When | Cause | Heard Best | Duration |
|---|---|---|---|---|
| S1 (Lub) | Start of IVC | Closure of MITRAL + TRICUSPID valves | Apex | Long, low |
| S2 (Dub) | Start of IVR | Closure of AORTIC + PULMONARY valves | Base | Short, sharp |
| S3 | Rapid ventricular filling | Vibration of ventricular walls | Apex | Low-pitched |
| S4 | Atrial systole | Stiff ventricle resisting filling | Apex | Low-pitched, presystolic |
Mnemonic: "Many Tiny Puppies Are": M=Mitral, T=Tricuspid → S1; P=Pulmonary, A=Aortic → S2
| Parameter | Value |
|---|---|
| EDV | 130 ml |
| ESV | 50 ml |
| Stroke Volume | 80 ml |
| Ejection Fraction | ~62% |
| Peak LV systolic pressure | 120 mmHg |
| LV diastolic pressure | ~0 mmHg |
| Heart rate | 75/min |
| Cardiac Output | 5 L/min |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. Both cardiac valves are closed during: | A) Rapid filling B) Rapid ejection C) Isovolumetric contraction D) Atrial systole | C (and also IVR) | IVC: both valves closed; pressure builds without volume change |
| 2. S1 heart sound is produced by: | A) Aortic + Pulmonary valve closure B) Mitral + Tricuspid valve closure C) Opening of mitral valve D) Ventricular filling | B | S1 = closure of AV valves at start of systole |
| 3. Stroke volume equals: | A) ESV B) EDV C) EDV - ESV D) EDV + ESV | C | SV = EDV - ESV = 130-50 = 80ml |
| 4. Preload of the heart is determined by: | A) End systolic volume B) End diastolic volume C) Aortic pressure D) Peripheral resistance | B | Preload = EDV = ventricular filling |
| 5. During isovolumetric contraction, which statement is true? | A) Volume increases B) Aortic valve opens C) Both valves closed D) Blood enters aorta | C | IVC = both valves closed, no volume change, pressure rises |
| 6. The dicrotic notch on aortic pressure tracing is due to: | A) Opening of aortic valve B) Closure of aortic valve C) Atrial contraction D) Rapid filling | B | Aortic valve closure causes brief backflow and notch |
| 7. Ejection fraction in a healthy adult is approximately: | A) 35% B) 45% C) 62% D) 80% | C | Normal EF = 55-70%; ~62% at rest |
| 8. Normal duration of cardiac cycle at HR 75/min is: | A) 0.6 sec B) 0.8 sec C) 1.0 sec D) 1.2 sec | B | 60/75 = 0.8 seconds |
| 9. "Atrial kick" contributes what percentage of ventricular filling? | A) 10% B) 25-30% C) 50% D) 70% | B | Atrial systole adds 25-30% to filling |
| 10. Cardiac output is increased in all EXCEPT: | A) Beriberi B) AV fistula C) Hyperthyroidism D) Aortic stenosis | D | Aortic stenosis reduces forward flow; others increase CO |
| Order | Topic | System | Yield |
|---|---|---|---|
| ✅ 1 | Cardiac Cycle (Pressure & Volume Changes) | CVS | Must Know |
| → 2 | Cardiac Output - Regulation & Measurement | CVS | Must Know |
| 3 | Arterial Blood Pressure - Regulation & Baroreceptors | CVS | Must Know |
| 4 | ECG - Waves, Intervals, Diagram | CVS | High |
| 5 | Shock - Hypovolaemic & Compensatory Mechanisms | CVS | High |
| 6 | O2-Hb Dissociation Curve + O2 Transport + Bohr Effect | Respiratory | Must Know |
| 7 | Hypoxia + Dead Space | Respiratory | Must Know |
| 8 | Environmental Physiology (CO poisoning, Decompression, High altitude) | Respiratory | High |
| 9 | Thyroid Hormones + Hyperthyroidism/Hypothyroidism | Endocrine | Must Know |
| 10 | Glucocorticoids + Cushing's Syndrome | Endocrine | Must Know |
| 11 | Insulin + Diabetes Mellitus | Endocrine | Must Know |
| 12 | Menstrual Cycle + Spermatogenesis | Reproductive | Must Know |
| 13 | GIT - Deglutition + Gastric Juice + Intestinal Movements | GIT | High |
| 14 | Bilirubin Metabolism + Jaundice | GIT | High |
| 15 | Temperature Regulation | Temp | High |
| 16 | Exercise Physiology - Cardiorespiratory changes | Exercise | High |
| 17 | Pituitary + Calcium + Aldosterone | Endocrine | Moderate |
| 18 | AETCOM - Doctor-Patient Relationship | AETCOM | Moderate |
Next
Cardiac Output (CO) is the total volume of blood pumped by each ventricle per minute.
Cardiac Output = Stroke Volume × Heart Rate
| Parameter | Normal Value |
|---|---|
| Stroke Volume (SV) | 70-80 ml/beat |
| Heart Rate (HR) | 72 beats/min |
| Cardiac Output (CO) | ~5000 ml/min = 5 L/min |
| Term | Definition | Normal Value |
|---|---|---|
| Stroke Volume (SV) | Volume ejected by each ventricle per beat | 70-80 ml |
| Cardiac Output (CO) | Volume pumped by ventricle per minute = SV × HR | 5 L/min |
| Cardiac Index (CI) | CO corrected for body surface area = CO / BSA | 3.2 L/min/m² |
| Ejection Fraction (EF) | Percentage of EDV ejected per beat = SV/EDV × 100 | 60-65% |
| Cardiac Reserve | Ability of heart to increase CO above resting level | 4-5x during maximal exercise |
| Venous Return (VR) | Volume of blood returning to right heart per minute | = CO in steady state (5 L/min) |
Key exam point: In steady state, Cardiac Output = Venous Return. If they are not equal, blood accumulates or is depleted from the heart - which cannot occur for long.
"The energy of contraction is proportional to the initial length of the cardiac muscle fiber."
- Otto Frank (pressure-volume relationship in frog heart)
- Ernest Starling (isolated dog heart, venous return experiments)
| Stimulus | Effect | Mechanism |
|---|---|---|
| Sympathetic (NE/Epi, β1 receptors) | ↑ HR (positive chronotropy) | Increases slope of pacemaker potential (If current) in SA node |
| Parasympathetic (ACh, M2 receptors) | ↓ HR (negative chronotropy) | Hyperpolarizes SA node (opens K⁺ channels via Gi protein) |
| High body temperature | ↑ HR | Direct effect on SA node firing rate |
| Hypothyroidism | ↓ HR | Reduced metabolic drive on SA node |
| Hyperthyroidism | ↑ HR | Increased β-adrenergic sensitization + metabolic demand |
| Condition | Mechanism | Increase in CO |
|---|---|---|
| Exercise | ↑ HR + ↑ SV + ↑ venous return | Up to 20-25 L/min (5x) |
| Hyperthyroidism | ↑ HR + ↑ metabolic demand + positive inotropic effect | Significantly elevated |
| AV Fistula (Arteriovenous fistula) | Blood bypasses capillaries → increased venous return → ↑ preload | Elevated |
| Beriberi (Vitamin B1 / Thiamine deficiency) | Peripheral vasodilation (nutritional) → ↓ TPR → ↑ venous return | High-output cardiac failure |
| Anaemia | ↓ blood viscosity + reflex tachycardia to compensate for low O2 delivery | Elevated |
| Pregnancy | ↑ blood volume + ↑ metabolic demand + low TPR placenta | Elevated by 30-50% |
| Fever | ↑ HR (10 bpm per 1°C rise) + vasodilation | Elevated |
Mnemonic for high-CO states: "HAPBEAT" - Hyperthyroidism, AV fistula, Pregnancy, Beriberi, Exercise, Anaemia, Temperature/fever
"The total uptake or release of any substance by an organ equals the blood flow through that organ multiplied by the difference in the substance's concentration between arterial and venous blood of that organ."
O₂ Consumed per minute (mL O₂/min)
CO = ─────────────────────────────────────────────────────
Arterial O₂ content - Mixed Venous O₂ content (mL O₂/L blood)
CO = 250 mL/min ÷ 50 mL/L = 5 L/min ✓
Amount of indicator injected (mg)
CO = ─────────────────────────────────────────────────────────
Area under concentration-time curve (mg/L × min)
| Method | Principle | Invasiveness | Clinical Use |
|---|---|---|---|
| Fick's Principle | O₂ consumption / AV O₂ difference | Invasive (cardiac catheter) | Gold standard; research |
| Dye Dilution | Stewart-Hamilton; Cardiogreen dye | Semi-invasive | ICU, cath lab |
| Thermodilution | Cold saline via Swan-Ganz | Semi-invasive (central line) | Most common ICU method |
| Echocardiography | SV × HR by imaging | Non-invasive | Most common clinical use |
| Ballistocardiography | Body recoil | Non-invasive | Historical |
CARDIAC OUTPUT = STROKE VOLUME × HEART RATE
| |
| |
┌────┴────┐ ┌────┴────┐
│ │ │ │
PRELOAD AFTERLOAD SYMPATHETIC PARASYMPATHETIC
(EDV) (TPR/BP) (↑ HR) (↓ HR)
│ │ │
↓ ↓ HORMONES
STARLING ↓SV if (Adrenaline,
LAW ↑afterload T3/T4)
│
CONTRACTILITY
(Inotropy)
Positive: Sympathetic,
Digoxin, Ca²⁺
Negative: β-blockers,
Heart failure, Hypoxia
| Type of Shock | Primary Problem | CO | TPR |
|---|---|---|---|
| Hypovolaemic | ↓ Blood volume → ↓ preload | Low | High (compensatory) |
| Cardiogenic | ↓ Contractility | Very Low | High |
| Distributive (septic) | ↓ TPR (vasodilation) | High (early) then Low | Low |
| Obstructive (PE, tamponade) | Mechanical obstruction to flow | Low | High |
| Factor | Effect on HR | Mechanism |
|---|---|---|
| Sympathetic stimulation | ↑ HR | Increased If current in SA node (β1 receptors) |
| Parasympathetic stimulation | ↓ HR | Hyperpolarizes SA node (M2, K⁺ channels) |
| Thyroid hormones | ↑ HR | ↑ β receptor sensitivity + metabolic rate |
| Bainbridge reflex | ↑ HR | Atrial stretch → reflex tachycardia |
| Body temperature | ↑ HR with fever | Direct SA node effect |
"The amount of a substance taken up by an organ per unit time equals blood flow to that organ multiplied by the A-V difference of that substance."
O₂ Consumption (mL/min)
CO = ──────────────────────────────────────────────────
Arterial O₂ content - Mixed Venous O₂ content (mL/L)
| Parameter | Patient Value | Normal Value | Interpretation |
|---|---|---|---|
| Stroke Volume | 50 ml | 70-80 ml | Reduced |
| Cardiac Output | 3.5 L/min | 4.5-6 L/min | Below normal |
| Cardiac Index | 2.06 L/min/m² | 2.8-3.6 L/min/m² | Below normal |
| EF | 38.5% | 55-70% | Reduced (< 40%) |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. Cardiac output is increased in all EXCEPT: | A) Beriberi B) AV fistula C) Hyperthyroidism D) Aortic stenosis | D | Aortic stenosis increases afterload and reduces forward SV; others reduce TPR and increase CO |
| 2. Frank-Starling's law of the heart relates: | A) HR and BP B) EDV and SV C) ESV and afterload D) Heart rate and contractility | B | Starling: increased EDV (preload/filling) → increased SV |
| 3. Mixed venous blood for Fick's method is obtained from: | A) Antecubital vein B) Femoral vein C) Pulmonary artery D) Pulmonary vein | C | Only pulmonary artery has truly mixed venous blood from the whole body |
| 4. Normal cardiac index is: | A) 1.5-2 L/min/m² B) 2.8-3.6 L/min/m² C) 4-5 L/min/m² D) 5-6 L/min/m² | B | CI = CO/BSA; normal = 3.0-3.2 L/min/m² |
| 5. In Fick's method, if O₂ consumption = 300 mL/min and A-V O₂ diff = 60 mL/L, CO = : | A) 3 L/min B) 5 L/min C) 6 L/min D) 18 L/min | B | CO = 300/60 = 5 L/min |
| 6. Positive inotropic agents shift Starling curve: | A) Downward and right B) Upward and left C) No shift D) Downward and left | B | More force for same EDV = upward-left shift |
| 7. The most practical method of measuring CO at bedside is: | A) Fick's principle B) Dye dilution C) Thermodilution D) Ballistocardiography | C | Thermodilution (Swan-Ganz catheter) - repeatable, no blood sampling |
| 8. Normal Ejection Fraction is: | A) 35-45% B) 55-70% C) 75-85% D) 90% | B | EF = SV/EDV × 100 ≈ 60-65% |
| 9. Preload is best represented by: | A) Aortic pressure B) Peripheral vascular resistance C) End-diastolic volume D) End-systolic volume | C | Preload = EDV = degree of filling before contraction |
| 10. Bowditch effect (Treppe/staircase) is due to: | A) Increased preload B) Increased afterload C) Increased HR → increased contractility D) Vagal stimulation | C | Increased HR → more Ca²⁺ entry per unit time → increased contractility |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle - Pressure & Volume Changes | ✅ Done |
| 2 | Cardiac Output - Regulation & Measurement | ✅ Done |
| → 3 | Arterial Blood Pressure + Baroreceptor Mechanism | Next |
| 4 | ECG - Waves, Intervals, Diagram | Pending |
| 5 | Shock - Hypovolaemic & Compensatory Mechanisms | Pending |
| 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect | Pending |
| 7 | Hypoxia + Dead Space | Pending |
| 8 | Environmental Physiology | Pending |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next
| Term | Definition | Normal Value |
|---|---|---|
| Blood Pressure (BP) | The lateral pressure exerted by the column of blood on the walls of the blood vessels per unit area | 120/80 mmHg |
| Systolic BP | Peak pressure in arteries during ventricular systole (ejection) | 120 mmHg |
| Diastolic BP | Lowest pressure in arteries during ventricular diastole (filling) | 80 mmHg |
| Pulse Pressure (PP) | Difference between systolic and diastolic BP | 40 mmHg (120-80) |
| Mean Arterial Pressure (MAP) | Average pressure throughout the entire cardiac cycle | ~93 mmHg |
| Hypertension | Persistent BP > 140/90 mmHg | - |
| Hypotension | BP < 90/60 mmHg | - |
MAP = Diastolic BP + 1/3 (Pulse Pressure) MAP = DBP + 1/3 (SBP - DBP)
MAP = (SBP + 2×DBP) / 3 = (120 + 160) / 3 = 93 mmHg
MAP = Cardiac Output × Total Peripheral Resistance MAP = CO × TPR
| Factor | Definition | Changes BP by |
|---|---|---|
| Cardiac Output (CO) | SV × HR | ↑CO → ↑MAP |
| Total Peripheral Resistance (TPR) | Resistance to blood flow in arterioles | ↑TPR → ↑MAP |
| Blood Volume | Total circulating blood | ↑ Vol → ↑ venous return → ↑ CO → ↑MAP |
| Viscosity of Blood | Determined mainly by haematocrit | ↑ Viscosity → ↑ TPR → ↑MAP |
| Elasticity of arteries | Compliance of aorta and large vessels | ↓ Compliance (stiff aorta) → ↑ SBP (↑ Pulse Pressure) |
R = 8ηL / πr⁴
| Mechanism | Speed | Duration of Action | Primary Target |
|---|---|---|---|
| Nervous (Neural) mechanisms | Seconds | Minutes | Short-term; rapid correction |
| Hormonal mechanisms | Minutes to hours | Hours | Intermediate-term |
| Renal mechanisms | Hours to days | Days to lifetime | Long-term (most powerful) |
| Feature | Carotid Sinus Baroreceptors | Aortic Arch Baroreceptors |
|---|---|---|
| Location | Bifurcation of common carotid | Aortic arch |
| Nerve | Carotid sinus nerve → Glossopharyngeal (CN IX) | Vagus nerve (CN X) |
| Responds to | Both ↑ and ↓ in BP | Primarily ↑ in BP |
| Sensitivity | More sensitive | Less sensitive |
| Baroreceptor | Nerve | Cranial Nerve | Terminates in |
|---|---|---|---|
| Carotid Sinus | Carotid sinus nerve (Hering's nerve) | Glossopharyngeal (CN IX) | Nucleus Tractus Solitarius (NTS) of Medulla |
| Aortic Arch | Depressor nerve (aortic nerve) | Vagus (CN X) | Nucleus Tractus Solitarius (NTS) of Medulla |
↑ Arterial BP
↓
↑ Stretch of carotid sinus + aortic arch walls
↓
↑ Firing rate in CN IX (Hering's nerve) + CN X (depressor nerve)
↓
NTS of medulla activated (BP > set-point)
↓
┌──────────────────────────────────┐
↓ ↓
↑ Parasympathetic outflow ↓ Sympathetic outflow
(vagus → SA node) (to heart + vessels)
↓ ↓
↓ Heart Rate ↓ HR + ↓ Contractility
(Bradycardia) + Vasodilation
+ Venodilation
↓ ↓
↓ Cardiac Output ↓ TPR + ↓ Venous Return
↓ ↓
MAP = CO × TPR → ↓ MAP
↓
BP restored to normal
↓ Arterial BP (e.g., haemorrhage)
↓
↓ Stretch of carotid sinus + aortic arch
↓
↓ Firing rate in CN IX + CN X
↓
NTS signals BP below set-point
↓
┌──────────────────────────────────┐
↓ ↓
↓ Parasympathetic outflow ↑ Sympathetic outflow
(less vagal tone) (to heart + vessels)
↓ ↓
↑ Heart Rate ↑ HR + ↑ Contractility
(Tachycardia) + Arteriolar vasoconstriction
+ Venoconstriction
↓ ↓
↑ Cardiac Output ↑ TPR + ↑ Venous Return
↓ ↓
MAP = CO × TPR → ↑ MAP
↓
BP restored toward normal
↓ Renal perfusion pressure
↓
Juxtaglomerular (JG) cells of kidney sense ↓ stretch
↓
RENIN released (enzyme) → cleaves Angiotensinogen (liver)
↓
ANGIOTENSIN I (10 amino acids, inactive)
↓
ACE (Angiotensin Converting Enzyme) - in lungs mainly
↓
ANGIOTENSIN II (8 amino acids, highly active)
↓
┌───────────┬──────────────┬──────────────┐
↓ ↓ ↓ ↓
Vasoconstriction Adrenal cortex Thirst center Brain (NTS):
↑ TPR (zona glomerulosa) Hypothalamus ↑ ADH release
↓ ↓ from pituitary
ALDOSTERONE ↑ Water intake ↓
↓ ↑ Water retention
Kidney: ↑ Na⁺ + H₂O
retention
↑ Blood volume
↓
↑ CO (via preload) + ↑ TPR → ↑ MAP
| Catecholamine | Source | Receptors | Cardiovascular Effect |
|---|---|---|---|
| Noradrenaline (NE) | Sympathetic nerve terminals | α1 (mainly), β1 | ↑ TPR (vasoconstriction) + ↑ HR |
| Adrenaline (Epi) | Adrenal medulla | α1 + β1 + β2 | ↑ HR + ↑ contractility; mixed effect on TPR (β2 vasodilation in skeletal muscle) |
| Mechanism | Stimulus | Speed | Effect | Duration |
|---|---|---|---|---|
| Baroreceptor reflex | Stretch of vessel wall | Seconds | ↑ or ↓ HR, CO, TPR | Minutes |
| Chemoreceptor reflex | ↓ O₂, ↑ CO₂, ↓ pH | Seconds | ↑ TPR (vasoconstriction) | Minutes |
| Cushing reflex | Brain ischemia | Seconds | Intense ↑ BP | Emergency only |
| CNS ischemia response | ↓ cerebral blood flow | Seconds | Max sympathetic activation | Emergency |
| RAAS | ↓ BP, ↓ Na⁺ | Minutes-hours | ↑ TPR + ↑ blood volume | Hours-days |
| ADH/Vasopressin | ↑ osmolality, ↓ volume | Minutes | ↑ water retention + vasoconstriction | Hours |
| Catecholamines | Stress, haemorrhage | Seconds-minutes | ↑ HR, CO, TPR | Minutes |
| ANP | ↑ atrial stretch | Minutes | ↓ TPR, ↓ volume | Hours |
| Renal pressure natriuresis | ↑ BP | Hours-days | ↓ Blood volume | Indefinite - strongest |
| Phase | What Happens | BP | HR |
|---|---|---|---|
| I (Start of strain) | ↑ Intrathoracic pressure → squeeze aorta → ↑ BP briefly | ↑ briefly | ↓ briefly |
| II (During strain) | ↓ Venous return → ↓ CO → ↓ BP | ↓ | ↑ (baroreceptor reflex) |
| III (Release) | ↓ Intrathoracic pressure → sudden ↓ BP | ↓ briefly | ↑ briefly |
| IV (Recovery) | Venous return rebounds → ↑ BP transiently above normal | ↑ (overshoot) | ↓ (baroreceptor → bradycardia) |
| Type | Mechanism |
|---|---|
| Essential (Primary, 90-95%) | Unknown; multiple genes; salt sensitivity; sympathetic overactivity; RAAS overactivity |
| Renovascular | Renal artery stenosis → ↓ renal perfusion → ↑ renin → ↑ Ang II → ↑ BP |
| Primary hyperaldosteronism (Conn's) | ↑ Aldosterone → ↑ Na⁺ retention → ↑ blood volume → ↑ BP |
| Phaeochromocytoma | Adrenal medullary tumour → ↑ catecholamines → ↑ TPR + ↑ HR → ↑ BP |
| Cushing's syndrome | ↑ Cortisol → mineralocorticoid effect + sensitizes vessels to catecholamines |
| Effector | Sympathetic effect (when BP falls) | Parasympathetic effect (when BP rises) |
|---|---|---|
| SA node | ↑ HR | ↓ HR |
| Myocardium | ↑ Contractility | Minimal effect |
| Arterioles | Vasoconstriction → ↑ TPR | Vasodilation → ↓ TPR |
| Veins | Venoconstriction → ↑ venous return | Venodilation → ↓ venous return |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. Baroreceptors are located in: | A) Right atrium + Pulmonary artery B) Carotid sinus + Aortic arch C) Carotid body + Aortic body D) Jugular vein + Subclavian artery | B | Classic locations: carotid sinus + aortic arch |
| 2. Afferent nerve from carotid sinus baroreceptors: | A) CN X (Vagus) B) CN VII (Facial) C) CN IX (Glossopharyngeal) D) CN XI (Accessory) | C | Carotid sinus nerve (Hering's nerve) → CN IX |
| 3. Integration center for baroreceptor reflex: | A) Hypothalamus B) Nucleus Tractus Solitarius (NTS) C) Cerebellum D) Pons | B | NTS in medulla integrates all baroreceptor input |
| 4. Rise in blood pressure → baroreceptor reflex causes: | A) Tachycardia + vasoconstriction B) Bradycardia + vasodilation C) Tachycardia + vasodilation D) Bradycardia + vasoconstriction | B | Negative feedback: ↑ BP → ↑ baroreceptors → ↑ parasympathetic (bradycardia) + ↓ sympathetic (vasodilation) |
| 5. MAP = Diastolic BP + : | A) Pulse pressure B) 1/2 pulse pressure C) 1/3 pulse pressure D) 2/3 pulse pressure | C | MAP = DBP + 1/3 PP; 1/3 because diastole is 2/3 of cycle |
| 6. Cushing's triad consists of: | A) Hypotension + tachycardia + deep breathing B) Hypertension + bradycardia + irregular respiration C) Hypertension + tachycardia + apnoea D) Hypotension + bradycardia + Cheyne-Stokes | B | Cushing's reflex in raised ICP: intense vasoconstriction (↑ BP), reflex bradycardia, brainstem compression (irregular respiration) |
| 7. Aortic arch baroreceptors travel via: | A) CN IX B) CN V C) CN X (Vagus) D) CN XI | C | Depressor/aortic nerve → CN X (Vagus) → NTS |
| 8. Renin is secreted by: | A) Adrenal medulla B) Juxtaglomerular cells of kidney C) Liver D) Posterior pituitary | B | JG cells in afferent arterioles of kidney secrete renin |
| 9. ACE is found predominantly in: | A) Kidney B) Liver C) Lungs D) Heart | C | Pulmonary vascular endothelium has highest ACE concentration - whole CO passes through lungs each beat |
| 10. ANP is released when: | A) BP falls B) Atrial wall is stretched (↑ blood volume) C) ADH is low D) Renin is activated | B | ANP = counter-regulatory; released by atria on stretch → natriuresis, diuresis, vasodilation |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle | ✅ Done |
| 2 | Cardiac Output | ✅ Done |
| 3 | Blood Pressure + Baroreceptor Mechanism | ✅ Done |
| → 4 | ECG - Waves, Intervals, Diagram | Next |
| 5 | Shock - Hypovolaemic & Compensatory Mechanisms | Pending |
| 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect | Pending |
| 7 | Hypoxia + Dead Space | Pending |
| 8 | Environmental Physiology | Pending |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next
The Electrocardiogram (ECG) is a graphic recording of the electrical activity of the heart as detected on the surface of the body by electrodes placed at various positions.
SA Node (Pacemaker)
↓ (Interatrial + Internodal pathways) → Atrial depolarization → P wave
AV Node (Delay: 0.1 sec) → PR interval (isoelectric = flat)
↓
Bundle of His
↓
Right + Left Bundle Branches
↓
Purkinje Fibers → Rapid ventricular depolarization → QRS complex
↓
Ventricular repolarization → T wave
| Structure | Conduction Velocity | Purpose |
|---|---|---|
| SA Node | 0.05 m/sec | Slow - initiates impulse |
| Atrial muscle | 1.0 m/sec | Spreads through atria |
| AV Node | 0.05 m/sec (slowest) | Deliberate delay - allows atria to finish contracting before ventricles start |
| Bundle of His | 1.0 m/sec | Transition zone |
| Bundle branches | 2.0 m/sec | Rapid spread |
| Purkinje fibers | 4.0 m/sec (fastest) | Ensures synchronous ventricular contraction |
| Ventricular muscle | 1.0 m/sec | End distribution |
Key exam point: AV node is the slowest (gate-keeper); Purkinje fibers are the fastest. AV node delay (0.1 sec) = PR interval isoelectric portion = allows atria to fully contract before ventricles.
| Feature | Detail |
|---|---|
| Represents | Atrial depolarization (spread from SA node through both atria) |
| Duration | 0.08-0.10 sec (80-100 ms) |
| Amplitude | < 2.5 mm (< 0.25 mV) |
| Shape | Rounded, monophasic, upright in Lead II |
| In Lead II | Always positive (upright) in normal sinus rhythm |
| Clinical note | Atrial repolarization is NOT visible - it is buried/hidden within the QRS complex (too small, masked by large QRS) |
| Feature | Detail |
|---|---|
| Represents | Ventricular depolarization |
| Components | Q wave (first downward), R wave (upward), S wave (downward after R) |
| Duration | 0.06-0.10 sec (< 0.12 sec = 3 small squares) |
| Amplitude | R wave typically 5-30 mm depending on lead |
| Why QRS duration ≈ P wave duration? | Despite ventricles being larger than atria, the His-Purkinje system is extremely fast (4 m/sec), so ventricular depolarization is completed just as quickly as atrial depolarization through slower pathways |
Abnormal Q wave: Wide (> 0.04 sec) and deep (> 25% of R wave height) Q waves = pathological Q waves = sign of old myocardial infarction (dead tissue cannot depolarize)
| Feature | Detail |
|---|---|
| Represents | Ventricular repolarization |
| Direction | Same as QRS complex (both upright in most leads) |
| Duration | 0.16 sec |
| Amplitude | < 5 mm in limb leads, < 10 mm in precordial leads |
| Event | Why not visible |
|---|---|
| Atrial repolarization | Small signal, buried within QRS complex (atria repolarize during ventricular depolarization) |
| SA node depolarization | SA node is too small to generate recordable surface potential |
| AV node depolarization | AV node is too small; AV conduction shows as isoelectric PR segment only |
| Measurement | What it covers | Normal Value | Clinical Significance |
|---|---|---|---|
| P wave duration | Atrial depolarization | 0.08-0.10 sec | Prolonged = intra-atrial block / left atrial enlargement |
| PR interval | Start of atrial depolarization → start of ventricular depolarization | 0.12-0.20 sec (3-5 small squares) | Prolonged = AV block; Short = WPW syndrome |
| PR segment | End of P wave → start of QRS (isoelectric) | Part of PR interval | Represents AV nodal conduction (delay) |
| QRS duration | Ventricular depolarization | 0.06-0.10 sec (< 3 small squares) | Prolonged > 0.12 sec = Bundle branch block / ventricular rhythm |
| ST segment | End of QRS → start of T wave (isoelectric) | Flat at baseline | Elevated = MI (injury); Depressed = ischaemia |
| QT interval | Start of QRS → end of T wave | 0.35-0.44 sec (rate-dependent) | Prolonged = risk of Torsades de Pointes (fatal arrhythmia) |
| R-R interval | One R wave to next R wave | 0.8 sec (at 75/min) | Measures heart rate; irregular = arrhythmia |
| T wave | Ventricular repolarization | < 5 mm limb, < 10 mm precordial | Peaked = hyperkalaemia; Flat/inverted = ischaemia |
| U wave | Papillary muscle/Purkinje repolarization | Small positive after T wave | Prominent = hypokalaemia |
| Lead | Positive Electrode | Negative Electrode | Views heart from |
|---|---|---|---|
| Lead I | Left arm (LA) | Right arm (RA) | Lateral (0°) |
| Lead II | Left leg (LL) | Right arm (RA) | Inferior (60°) |
| Lead III | Left leg (LL) | Left arm (LA) | Inferior (120°) |
Lead I = Left arm is POSITIVE (+ve), Right arm is NEGATIVE (-ve) A positive deflection in Lead I means the electrical impulse is moving from Right arm toward Left arm (left direction)
Lead I + Lead III = Lead II (At any moment: the sum of voltages in Lead I and Lead III equals Lead II)
| Lead | Positive Electrode | Views |
|---|---|---|
| aVR | Right arm | Rightward direction (−150°) |
| aVL | Left arm | Lateral (−30°) |
| aVF | Left foot (LL) | Inferior (+90°) |
| Lead | Position | Views |
|---|---|---|
| V1 | 4th ICS, right sternal border | Septal |
| V2 | 4th ICS, left sternal border | Septal |
| V3 | Between V2 and V4 | Anterior |
| V4 | 5th ICS, mid-clavicular line | Anterior |
| V5 | 5th ICS, anterior axillary line | Lateral |
| V6 | 5th ICS, mid-axillary line | Lateral |
The Mean Electrical Axis is the average direction of the ventricular depolarization vector (mean QRS vector) in the frontal plane, expressed in degrees.
| Axis | Degree Range | Clinical Meaning |
|---|---|---|
| Normal axis | -30° to +90° | Normal |
| Left axis deviation (LAD) | < -30° (up to -90°) | Left ventricular hypertrophy, LBBB, inferior MI |
| Right axis deviation (RAD) | > +90° (up to +180°) | Right ventricular hypertrophy, RBBB, lung disease |
| Extreme axis deviation | -90° to +180° | Ventricular tachycardia, severe disease |
Answer: +59 degrees (commonly stated as approximately +60°, range -30° to +90°) This reflects the fact that the main ventricular activation travels toward the left and inferior direction (toward the apex), which corresponds to approximately +60° in the frontal plane.
| Division | Size | Time |
|---|---|---|
| Small square | 1 mm × 1 mm | 0.04 sec horizontally |
| Large square (5 small) | 5 mm × 5 mm | 0.20 sec horizontally |
| Vertical: 1 mm | - | 0.1 mV amplitude |
| Vertical: 10 mm (= 1 cm) | - | 1 mV (standard calibration) |
| ECG Event | Cardiac Mechanical Event |
|---|---|
| P wave | Atrial systole (contraction) follows ~0.08 sec after P wave begins |
| PR interval (isoelectric) | AV node delay; atria contracting, ventricles still relaxed (filling) |
| QRS complex | Ventricular isovolumetric contraction begins; S1 occurs just after QRS |
| ST segment | Ventricular ejection (plateau of action potential = maintained depolarization) |
| T wave | Ventricular repolarization; IVR begins; S2 occurs near end of T wave |
| After T wave | Rapid ventricular filling (diastole) |
| R-R interval | One complete cardiac cycle |
| Territory | Artery | ECG Leads |
|---|---|---|
| Anterior | LAD | V1-V4 |
| Inferior | RCA | II, III, aVF |
| Lateral | Circumflex | I, aVL, V5-V6 |
| Posterior | RCA/Circumflex | Tall R in V1-V2 |
| Wave/Interval | Represents | Normal Value |
|---|---|---|
| P wave | Atrial depolarization | Duration: 0.08-0.10 sec; Amplitude < 2.5 mm |
| QRS complex | Ventricular depolarization | Duration: 0.06-0.10 sec (< 3 small squares) |
| T wave | Ventricular repolarization | Amplitude < 5 mm in limb leads |
| PR interval | SA node to start of ventricular depolarization (includes AV conduction delay) | 0.12-0.20 sec |
| ST segment | Ventricular plateau (isoelectric) | Flat at baseline |
| QT interval | Ventricular depolarization + repolarization | 0.35-0.44 sec (rate-dependent) |
| R-R interval | One complete cardiac cycle | 0.8 sec (at HR 75/min) |
| Abnormality | ECG Change |
|---|---|
| 1st degree AV block | Prolonged PR > 0.20 sec |
| Bundle branch block | Wide QRS > 0.12 sec |
| Myocardial infarction | ST elevation + pathological Q waves |
| Hyperkalaemia | Tall peaked T waves |
| WPW syndrome | Short PR + delta wave + wide QRS |
| Structure | ECG | Duration |
|---|---|---|
| SA node | (not visible) | - |
| Atria | P wave | 0.08-0.10 sec |
| AV node/His | PR segment | ~0.06-0.10 sec |
| Bundle branches + Purkinje | QRS complex | 0.06-0.10 sec |
| Ventricular muscle | ST segment + T wave | - |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. ECG Lead I connections: | A) RA +ve, LA -ve B) LA +ve, RA -ve C) RA +ve, LL -ve D) LA +ve, LL -ve | B | Lead I = LA positive, RA negative (Einthoven's convention) |
| 2. Normal mean QRS axis: | A) +49° B) +59° C) +69° D) +79° | B | ~+59-60° (normal range -30° to +90°); LV dominance directs vector left-inferior |
| 3. QRS complex represents: | A) Atrial depolarization B) Ventricular depolarization C) Ventricular repolarization D) AV node conduction | B | QRS = ventricular depolarization (P = atrial depol; T = ventricular repol) |
| 4. Normal PR interval is: | A) 0.04-0.08 sec B) 0.08-0.10 sec C) 0.12-0.20 sec D) 0.30-0.44 sec | C | PR interval = 0.12-0.20 sec; includes AV node delay |
| 5. Atrial repolarization is not visible on ECG because: | A) It does not produce electrical activity B) It is buried in QRS complex C) It occurs after T wave D) It is seen as U wave | B | Atrial repolarization signal is small and coincides with large QRS → buried/masked |
| 6. Fastest conduction velocity in the heart: | A) SA node B) AV node (slowest) C) Purkinje fibers D) Ventricular muscle | C | Purkinje fibers: 4 m/sec (fastest). AV node: 0.05 m/sec (slowest) |
| 7. Prolonged QT interval predisposes to: | A) Complete heart block B) Atrial flutter C) Torsades de Pointes D) WPW syndrome | C | Prolonged QT → Torsades de Pointes → can degenerate to VF → sudden death |
| 8. PR interval is prolonged (>0.20 sec) in: | A) WPW syndrome B) First degree AV block C) Bundle branch block D) Ventricular tachycardia | B | Prolonged PR = 1st degree AV block (slow AV node conduction); WPW has SHORT PR |
| 9. On ECG paper at 25 mm/sec, one small square = : | A) 0.02 sec B) 0.04 sec C) 0.10 sec D) 0.20 sec | B | Standard: small square = 1 mm = 0.04 sec; large square = 5 mm = 0.20 sec |
| 10. Heart rate from ECG if R-R interval spans 5 large squares: | A) 50/min B) 60/min C) 75/min D) 100/min | B | HR = 300/large squares = 300/5 = 60/min |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle | ✅ Done |
| 2 | Cardiac Output | ✅ Done |
| 3 | Blood Pressure + Baroreceptors | ✅ Done |
| 4 | ECG - Waves, Intervals, Diagram | ✅ Done |
| → 5 | Shock - Hypovolaemic & Compensatory Mechanisms | Next |
| 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect | Pending |
| 7 | Hypoxia + Dead Space | Pending |
| 8 | Environmental Physiology | Pending |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next
Shock is a state of systemic tissue hypoperfusion (inadequate tissue perfusion) due to reduced cardiac output and/or reduced effective circulating blood volume, leading to cellular hypoxia and, if prolonged, irreversible tissue injury and death.
| Type | Primary Defect | CO | TPR | CVP |
|---|---|---|---|---|
| 1. Hypovolaemic | ↓ Blood/plasma volume → ↓ venous return | Low | High | Low |
| 2. Cardiogenic | ↓ Cardiac pump function | Very Low | High | High |
| 3. Distributive | Maldistribution of blood flow (vasodilation) | High (early) | Very Low | Low |
| 4. Obstructive | Mechanical obstruction to blood flow | Low | High | High/Low |
Cardiogenic vs Distributive: In cardiogenic → CO is LOW, TPR is HIGH (vasoconstriction compensates); in distributive → CO is HIGH (early), TPR is very LOW (peripheral vasodilation is the primary defect)
| Feature | Compensated | Progressive (Decompensated) | Irreversible |
|---|---|---|---|
| Blood loss | < 15-20% | 20-40% | > 40% |
| BP | Normal | Low | Very Low / 0 |
| HR | Mildly ↑ (100-120) | Markedly ↑ (>120) | Bradycardia / Stop |
| Urine output | Slightly ↓ | Oliguria | Anuria |
| Consciousness | Anxious | Confused | Unconscious |
| Reversibility | Yes - responds to treatment | Yes if treated early | No |
| Key event | Baroreceptor reflex + RAAS active | Vicious cycle begins; lactic acidosis | Cell death + MODS |
Venoconstriction is critically important: Veins normally hold 60-70% of blood volume. Venoconstriction squeezes blood from this reservoir back to the heart → immediate increase in preload and CO. This is the body's first-line auto-transfusion.
HAEMORRHAGE (blood loss)
↓
↓ Blood volume → ↓ Venous return → ↓ EDV
↓
↓ Stroke Volume → ↓ Cardiac Output → ↓ MAP
↓
┌─────┴──────────────────────┐
↓ ↓
NEURAL (seconds) HORMONAL (minutes-hours)
↓ ↓
↓ Baroreceptor firing ↑ Renin → Ang II → Aldosterone
↓ ↑ ADH → Water retention
↑ Sympathetic: ↑ Catecholamines
↑ HR (tachycardia) ↑ Cortisol
↑ Contractility ↓
Arteriolar vasoconstriction ↑ Na⁺/H₂O retention
Venoconstriction ↑ Vasoconstriction
↑ Adrenal catecholamines ↓
↓ Parasympathetic ↑ Blood volume
↓ ↓
↑ CO + ↑ TPR ↑ Venous return → ↑ CO
↓
TRANSCAPILLARY FLUID SHIFT
(Interstitium → Capillary = autotransfusion)
↓
All mechanisms combined → ↑ MAP → Restore tissue perfusion
| Class | Blood Loss | % Volume | HR | BP | RR | Urine Output | Mental Status |
|---|---|---|---|---|---|---|---|
| I | < 750 ml | < 15% | < 100 | Normal | 14-20 | Normal | Normal/Anxious |
| II | 750-1500 ml | 15-30% | 100-120 | Normal | 20-30 | Decreased | Anxious |
| III | 1500-2000 ml | 30-40% | 120-140 | Decreased | 30-40 | < 30 ml/hr | Confused |
| IV | > 2000 ml | > 40% | > 140 | Very Low | > 35 | Anuria | Lethargic/Coma |
Class I-II = Compensated; Class III-IV = Decompensated/Progressive
| Feature | Hypovolaemic | Cardiogenic |
|---|---|---|
| Cause | Blood/fluid loss | MI, arrhythmia, tamponade |
| CO | Low | Very Low |
| TPR | High (cold, clammy skin) | High (cold, clammy skin) |
| JVP/CVP | Low (flat neck veins) | High (distended neck veins, pulmonary oedema) |
| Lung sounds | Clear | Crackles (pulmonary oedema) |
| Treatment | IV Fluids | Inotropes (not fluids - would worsen pulmonary oedema) |
The most important bedside distinction: In hypovolaemic shock, JVP is LOW (empty veins). In cardiogenic shock, JVP is HIGH (backed-up blood). This dictates completely opposite treatment.
| Compensation | Clinical sign |
|---|---|
| ↑ HR | Tachycardia (> 100/min) |
| Venoconstriction | Full peripheral veins initially |
| Arteriolar constriction | Pale, cold, clammy skin |
| ADH effect | Oliguria, dark concentrated urine |
| RAAS | ↑ Thirst |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. In hypovolaemic shock, cardiac output is: | A) High B) Normal C) Low D) Variable | C | ↓ Blood volume → ↓ venous return → ↓ CO |
| 2. Which feature distinguishes neurogenic from hypovolaemic shock? | A) Hypotension B) Tachycardia C) Bradycardia D) Oliguria | C | Neurogenic: loss of sympathetic → bradycardia (vagus unopposed); Hypovolaemic: tachycardia |
| 3. In cardiogenic shock, JVP is: | A) Low B) Normal C) High D) Absent | C | Pump failure → blood backs up → high JVP + pulmonary oedema |
| 4. First compensatory mechanism in haemorrhagic shock: | A) RAAS activation B) ADH release C) Baroreceptor reflex (sympathetic) D) Transcapillary fluid shift | C | Baroreceptor reflex acts within seconds - fastest response |
| 5. Oliguria in shock is caused by: | A) ↑ ADH + Aldosterone + renal vasoconstriction B) ↓ ADH C) ↑ ANP D) Direct renal damage only | A | All three mechanisms reduce urine output (ADH = water retention, Aldosterone = Na⁺ retention, vasoconstriction = ↓ GFR) |
| 6. Irreversible shock is characterized by: | A) Low BP only B) Oliguria C) Multi-organ failure not responsive to treatment D) Tachycardia | C | Irreversible = MODS, cell death, unresponsive to resuscitation |
| 7. Best bedside marker of tissue perfusion after resuscitation: | A) Blood pressure B) Heart rate C) Urine output D) Temperature | C | Urine output (> 0.5 ml/kg/hr = adequate renal/splanchnic perfusion) is most sensitive |
| 8. Distributive shock is characterized by: | A) High CO + Low TPR B) Low CO + High TPR C) High CO + High TPR D) Low CO + Low TPR | A | Distributive (septic/neurogenic/anaphylactic): vasodilation = low TPR; early compensatory high CO |
| 9. In progressive shock, the vicious cycle begins with: | A) Haemorrhage B) Arteriolar dilation due to ischaemic acidosis C) AV fistula D) Cardiac hypertrophy | B | Pre-capillary sphincters open due to local acidosis → capillary pooling → further ↓ venous return → cycle begins |
| 10. Treatment of anaphylactic shock: | A) IV fluids only B) Dopamine C) IM Adrenaline (epinephrine) D) Noradrenaline | C | Adrenaline (IM) = α1 (vasoconstriction) + β2 (bronchodilation + mast cell stabilization) = drug of choice |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle | ✅ Done |
| 2 | Cardiac Output | ✅ Done |
| 3 | Blood Pressure + Baroreceptors | ✅ Done |
| 4 | ECG | ✅ Done |
| 5 | Shock - Classification, Stages & Compensatory Mechanisms | ✅ Done |
| → 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect + P50 | Next |
| 7 | Hypoxia + Dead Space | Pending |
| 8 | Environmental Physiology (CO poisoning, Decompression, Altitude) | Pending |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next
| Form | Amount | Details |
|---|---|---|
| Combined with Haemoglobin (HbO₂) | 97% | Chemical combination; reversible; main transport |
| Dissolved in plasma | 3% | Dissolved in water phase; follows Henry's law: amount α PO₂ |
Key point: 97% is Hb-bound; 3% dissolved. Without Hb, dissolved O₂ alone would be completely inadequate for life. This is why anaemia or CO poisoning is so dangerous - even if plasma PO₂ is normal, total O₂ content is severely reduced.
| Parameter | Value | Where/Condition |
|---|---|---|
| Arterial PO₂ | 95 mmHg | Pulmonary capillaries / systemic arteries |
| Arterial Hb saturation (SaO₂) | 97% | Arterial blood |
| Arterial O₂ content | 19.4 mL/100 mL | At 97% saturation |
| Venous PO₂ | 40 mmHg | Tissue capillaries / mixed venous blood |
| Venous Hb saturation (SvO₂) | 75% | Mixed venous blood (resting) |
| Venous O₂ content | 14.4 mL/100 mL | At 75% saturation |
| O₂ delivered to tissues | 5 mL per 100 mL blood | Difference (19.4 - 14.4) per cycle |
| P50 (normal) | 26-27 mmHg | PO₂ at which Hb is 50% saturated |
| O₂ carrying capacity | 20.1 mL/100 mL | At 100% saturation |
The O₂-Hb dissociation curve is a graphical representation of the relationship between the partial pressure of oxygen (PO₂) in blood and the percentage saturation of haemoglobin with oxygen (SaO₂).
| Region of Curve | PO₂ | SaO₂ | Physiological meaning |
|---|---|---|---|
| Upper flat portion | 60-100 mmHg | ~90-97% | In lungs: Hb loads O₂ efficiently. Even if alveolar PO₂ falls from 100 to 60 mmHg (e.g., altitude), saturation barely changes (97% → 90%). This is the safety margin of O₂ loading |
| Steep middle portion | 20-60 mmHg | 40-75% | In tissues: Small fall in PO₂ releases large amount of O₂. Essential for efficient unloading at tissues |
| Lower flat portion | 0-20 mmHg | 0-35% | Extreme O₂ extraction possible during maximum exercise/severe hypoxia |
| Cause | Mechanism |
|---|---|
| ↑ CO₂ (hypercapnia) | Direct effect on Hb + Bohr effect (CO₂ → H⁺) |
| ↑ H⁺ (Acidosis, ↓ pH) | Bohr Effect (H⁺ bind to globin → allosteric change → ↓ affinity) |
| ↑ DPG (2,3-Diphosphoglycerate = 2,3-BPG) | Binds β chains → stabilizes deoxy-Hb → ↓ affinity |
| ↑ Exercise (combined: ↑ CO₂, ↑ H⁺, ↑ Temp, ↑ 2,3-BPG) | All mechanisms combined |
| ↑ Temperature | Weakens H-bonds between O₂ and Hb |
| Cause | Mechanism |
|---|---|
| ↓ CO₂ (hypocapnia) | ↑ Hb-O₂ affinity |
| ↓ H⁺ (Alkalosis, ↑ pH) | Reverse Bohr Effect |
| ↓ 2,3-BPG | Hb retains O₂ more tightly |
| ↓ Temperature | Strengthens Hb-O₂ bonds |
| Carbon Monoxide (CO) | CO binds Fe²⁺ 250× more avidly than O₂; CO-Hb also left-shifts the remaining Hb |
| Fetal Hb (HbF) | γ chains instead of β → lower 2,3-BPG affinity → higher O₂ affinity than HbA |
| Methaemoglobinaemia | Fe³⁺ instead of Fe²⁺ → cannot bind O₂ |
The Bohr Effect is the shift of the O₂-Hb dissociation curve to the RIGHT caused by an increase in H⁺ ion concentration (decrease in pH) or an increase in CO₂, resulting in decreased Hb affinity for O₂ and enhanced O₂ release to tissues.
CO₂ produced by metabolism → enters RBCs
CO₂ + H₂O → H₂CO₃ (carbonic anhydrase) → H⁺ + HCO₃⁻
↑ H⁺ in RBC → binds to globin histidine residues
→ Allosteric change → T-state Hb (low O₂ affinity)
→ O₂ RELEASED from Hb → diffuses to tissues
→ RIGHT SHIFT of dissociation curve
CO₂ leaves blood → HCO₃⁻ + H⁺ → H₂CO₃ → H₂O + CO₂ (exhaled)
↓ H⁺ → H⁺ dissociates from globin → R-state Hb (high affinity)
→ O₂ LOADED onto Hb in pulmonary capillaries
→ LEFT SHIFT (relatively) at lungs → efficient O₂ loading
P50 is the partial pressure of oxygen (PO₂) at which haemoglobin is exactly 50% saturated with oxygen under standard conditions (pH 7.4, temp 37°C, PCO₂ 40 mmHg).
| Change in P50 | Meaning | Clinical Example |
|---|---|---|
| ↑ P50 (> 27 mmHg) | Right shift | Lower Hb affinity for O₂; more O₂ released at any given PO₂ |
| ↓ P50 (< 26 mmHg) | Left shift | Higher Hb affinity for O₂; less O₂ released |
| Hb Type | Feature | O₂ Affinity | Curve shift |
|---|---|---|---|
| HbA (Adult) | 2α + 2β | Normal | Normal |
| HbF (Foetal) | 2α + 2γ (no β) | HIGH (↑ 2,3-BPG) | LEFT shift (lower P50 ~18 mmHg) |
| HbS (Sickle cell) | Glutamic acid → Valine in β chain | Lower than HbA | Slightly right |
| HbCO (Carboxyhaemoglobin) | CO bound to Fe²⁺ | Remaining Hb: HIGH (double danger) | LEFT shift |
| Methaemoglobin | Fe³⁺ (oxidized) | Cannot bind O₂ | No curve (non-functional) |
| Measure | Definition | Formula | What it tells you |
|---|---|---|---|
| PO₂ | Partial pressure of O₂ in blood (dissolved) | Henry's law | Driving force for diffusion; how "available" O₂ is |
| SaO₂ | % Hb saturated with O₂ (pulse oximeter) | From dissociation curve | How full Hb "buckets" are |
| O₂ Content (CaO₂) | Total O₂ in blood (Hb-bound + dissolved) | (Hb × 1.34 × SaO₂/100) + (PO₂ × 0.003) | Actual amount of O₂ in blood |
The Haldane Effect is the phenomenon where oxygenation of blood promotes the release of CO₂ (and vice versa: deoxygenation of blood promotes CO₂ uptake).
| COHb% | Symptoms |
|---|---|
| 10% | Headache, mild fatigue |
| 20-30% | Nausea, headache, dizziness |
| 40-50% | Confusion, severe headache |
| 60-70% | Unconsciousness, convulsions |
| > 70% | Death |
| Step | Location | Process | Key Values |
|---|---|---|---|
| 1. Ventilation | Lungs | Atmospheric air → Alveoli | Atmospheric PO₂ = 159 mmHg; Alveolar PO₂ = 100 mmHg |
| 2. Alveolar diffusion | Alveolo-capillary membrane (6 layers) | O₂ diffuses down pressure gradient | Alveolar PO₂ = 100; Blood enters at PO₂ = 40 → equilibrates to 95 mmHg |
| 3. Loading onto Hb | Pulmonary capillaries | O₂ binds Hb → HbO₂ | SaO₂ = 97%; O₂ content = 19.4 mL/100 mL |
| 4. Circulation | Blood/cardiac output | 97% as HbO₂; 3% dissolved | DO₂ = 5 L/min × 200 mL/L = 1000 mL/min |
| 5. O₂ unloading | Tissue capillaries | O₂ released from Hb | Tissue PO₂ = 40 mmHg; SvO₂ = 75%; 5 mL released per 100 mL blood |
| 6. Cellular utilization | Mitochondria | O₂ + NADH → ATP (oxidative phosphorylation) | Critical intracellular PO₂ = 1 mmHg |
The Bohr Effect is the shift of the O₂-Hb dissociation curve to the right caused by an increase in H⁺ concentration (↓ pH) or increase in CO₂, resulting in decreased Hb affinity for O₂ and enhanced O₂ unloading at tissues.
| Factor | Examples |
|---|---|
| ↑ H⁺ / ↓ pH (acidosis) | Bohr Effect; lactic acidosis, CO₂ retention |
| ↑ PCO₂ | Tissue metabolism, COPD |
| ↑ Temperature | Fever, exercising muscle |
| ↑ 2,3-BPG | Anaemia, altitude, exercise, hypoxia |
| Factor | Examples |
|---|---|
| ↓ H⁺ / ↑ pH (alkalosis) | Hyperventilation |
| ↓ PCO₂ | Hyperventilation |
| ↓ Temperature | Hypothermia, cold blood transfusion |
| ↓ 2,3-BPG | Stored blood, hypothyroidism |
| CO binding | CO poisoning (also left-shifts remaining Hb) |
| HbF (fetal Hb) | Less 2,3-BPG binding |
| Condition | P50 | Shift |
|---|---|---|
| Normal adult (HbA) | 26-27 mmHg | - |
| Exercise, acidosis, fever | ↑ (> 27) | Right |
| CO poisoning, HbF, alkalosis | ↓ (< 26) | Left |
| Anaemia (↑ 2,3-BPG) | ↑ | Right |
| Stored blood (↓ 2,3-BPG) | ↓ | Left |
Cyanosis appears when deoxygenated Hb > 5 g/100 mL blood (5 gm%)
| Feature | Myoglobin | Haemoglobin |
|---|---|---|
| Location | Muscle cells | Red blood cells |
| Structure | 1 subunit, 1 haem | 4 subunits, 4 haem |
| Dissociation curve | Hyperbolic | Sigmoid (S-shaped) |
| O₂ affinity | Very high (P50 = 1-3 mmHg) | Lower (P50 = 26-27 mmHg) |
| Cooperativity | None (no cooperativity) | Yes (cooperative binding) |
| Function | O₂ storage in muscle; O₂ reserve for intense exercise | O₂ transport in blood |
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. O₂-Hb curve shifts to RIGHT in all EXCEPT: | A) Acidosis B) Hyperthermia C) Exercise D) Alkalosis | D | Alkalosis (↑ pH, ↓ H⁺) → LEFT shift (reverse Bohr). All others right-shift |
| 2. P50 of normal adult Hb: | A) 10 mmHg B) 18 mmHg C) 26-27 mmHg D) 40 mmHg | C | P50 = PO₂ at 50% saturation = 26-27 mmHg under standard conditions |
| 3. % of O₂ transported dissolved in plasma: | A) 3% B) 23% C) 50% D) 97% | A | 3% dissolved in plasma; 97% bound to Hb |
| 4. The Bohr Effect is caused by: | A) Increased O₂ B) Increased H⁺ and CO₂ C) Decreased temperature D) Carbon monoxide | B | Bohr = ↑ H⁺ / ↑ CO₂ → RIGHT shift → ↓ Hb affinity → more O₂ released |
| 5. Cyanosis appears when deoxygenated Hb exceeds: | A) 1 gm% B) 3 gm% C) 5 gm% D) 7 gm% | C | Classic threshold: > 5 gm% (5 g/100 mL) deoxygenated Hb |
| 6. CO poisoning: skin colour is: | A) Cyanotic B) Pale C) Cherry red D) Jaundiced | C | CO-Hb is bright cherry red → cherry red skin/mucous membranes |
| 7. HbF has LEFT-shifted curve because: | A) More 2,3-BPG binding B) Less 2,3-BPG binding (γ chains) C) More α chains D) Temperature effect | B | γ chains bind 2,3-BPG less → less T-state stabilization → higher affinity → left shift |
| 8. Oxygen carrying capacity of normal blood: | A) 10 mL/100 mL B) 15 mL/100 mL C) 20 mL/100 mL D) 25 mL/100 mL | C | 15 g Hb × 1.34 mL/g = ~20 mL O₂/100 mL at 100% saturation (20 vol%) |
| 9. Number of O₂ molecules each Hb molecule can carry: | A) 1 B) 2 C) 4 D) 8 | C | 4 haem groups × 1 O₂ each = 4 O₂ per Hb molecule |
| 10. In stored blood, O₂-Hb curve shifts LEFT due to: | A) ↑ 2,3-BPG B) ↓ 2,3-BPG (degraded) C) ↑ Temperature D) ↑ CO₂ | B | 2,3-BPG degrades in stored blood → ↑ Hb affinity → left shift → less O₂ delivered to tissues after transfusion |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle | ✅ Done |
| 2 | Cardiac Output | ✅ Done |
| 3 | Blood Pressure + Baroreceptors | ✅ Done |
| 4 | ECG | ✅ Done |
| 5 | Shock | ✅ Done |
| 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect + P50 | ✅ Done |
| → 7 | Hypoxia (Classification + Effects) + Dead Space | Next |
| 8 | Environmental Physiology (CO Poisoning, Decompression, Altitude) | Pending |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT (Deglutition + Gastric Juice + Intestinal Movements) | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next
| Term | Definition | Key Feature |
|---|---|---|
| Hypoxia | Inadequate O₂ delivery to tissues OR inability to use O₂ | Tissue level problem |
| Hypoxaemia | ↓ Arterial PO₂ (below 80 mmHg) | Blood level problem |
| Anoxia | Complete absence of O₂ | Extreme hypoxia |
| Asphyxia | Hypoxia + hypercapnia together (e.g., airway obstruction) | Both O₂↓ + CO₂↑ |
| Sub-type | Mechanism | Example |
|---|---|---|
| High altitude | ↓ Barometric pressure → ↓ PO₂ of inspired air → ↓ Alveolar PO₂ | Mountain climbing, aviation |
| Hypoventilation | ↓ Alveolar ventilation → CO₂ accumulates → displaces O₂ in alveolus | Opioid overdose, neuromuscular disease, COPD |
| Diffusion impairment | Thickened alveolo-capillary membrane → slows O₂ diffusion | Pulmonary fibrosis, pulmonary oedema, ARDS |
| V/Q mismatch | Ventilation-perfusion inequality → some alveoli ventilated but not perfused (dead space) or perfused but not ventilated (shunt) | COPD, asthma, pulmonary embolism |
| Right-to-left shunt | Deoxygenated blood bypasses lungs entirely | Congenital heart disease (Tetralogy of Fallot), AV malformations |
| Cause | Mechanism |
|---|---|
| Anaemia | ↓ Total Hb → ↓ O₂ carrying capacity |
| Carbon Monoxide poisoning | CO occupies Hb sites (250× affinity) + left shifts remaining Hb → "functional anaemia" |
| Methaemoglobinaemia | Fe²⁺ → Fe³⁺ (by drugs/chemicals) → cannot bind O₂ |
| Sulphaemoglobinaemia | Irreversible Hb change → non-functional |
| Type | Example |
|---|---|
| Generalised | Cardiac failure, shock (cardiogenic/hypovolaemic) |
| Regional/Local | Arterial occlusion (MI - coronary obstruction; stroke - cerebral), Raynaud's phenomenon, venous congestion |
| Feature | Hypoxic | Anaemic | Stagnant | Histotoxic |
|---|---|---|---|---|
| PaO₂ | ↓ | Normal | Normal | Normal |
| Hb content | Normal | ↓ | Normal | Normal |
| Hb saturation | ↓ | Normal | Normal | Normal |
| O₂ content of blood | ↓ | ↓ | Normal | Normal |
| Blood flow | Normal | Normal | ↓ | Normal |
| Cell utilization | Normal | Normal | Normal | ↓ (blocked) |
| A-V O₂ diff | Normal/↑ | Normal/↑ | ↑ (high extraction) | ↓ (can't extract) |
| Venous blood colour | Dark | Dark | Dark | Bright red |
| Cyanosis | Yes (if severe) | No (not enough Hb to turn blue) | Yes (peripheral) | No |
| Example | High altitude, COPD | Anaemia, CO poisoning | Heart failure, shock | Cyanide poisoning |
| Duration/Degree | CNS Effects |
|---|---|
| Mild hypoxia | Decreased concentration, impaired judgment, euphoria (like alcohol intoxication) |
| Moderate hypoxia | Headache, fatigue, dizziness, confusion, incoordination |
| Severe hypoxia | Loss of vision, delirium, convulsions, loss of consciousness |
| Complete anoxia | 4-6 min: Irreversible brain damage; > 10 min: brain death |
| Severity | Cellular Effect |
|---|---|
| Mild | Glycolysis ↑ (anaerobic pathway activated to compensate) |
| Moderate | ATP generation falls → Na⁺/K⁺ ATPase fails → cell swells (cytotoxic oedema) |
| Severe | Cell membrane disruption → Ca²⁺ influx → activation of proteases, lipases, nucleases |
| Extreme | Lysosomal enzymes released → autolysis → cell death → irreversible |
HYPOXIA
↓
┌─────────────────────────────────────────────┐
│ IMMEDIATE (seconds-minutes) │
│ Peripheral chemoreceptors → ↑ Ventilation │
│ ↑ HR + ↑ CO (sympathetic) │
│ Peripheral vasodilation │
│ CNS: Agitation → Confusion │
└─────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────┐
│ SHORT-TERM (hours-days) │
│ ↑ 2,3-BPG → Right shift O₂-Hb curve │
│ Hypoxic pulmonary vasoconstriction (HPV) │
│ ↑ EPO release starts │
└─────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────┐
│ LONG-TERM (weeks-months) │
│ Polycythaemia (EPO → ↑ RBC) │
│ ↑ Capillary density (angiogenesis via HIF) │
│ Pulmonary hypertension + Cor pulmonale │
└─────────────────────────────────────────────┘
Dead space is the volume of the respiratory system that is ventilated (receives inspired air) but does NOT participate in gas exchange (no O₂-CO₂ exchange with blood).
VD PaCO₂ - PECO₂
─── = ─────────────────
VT PaCO₂
| Type | Definition | Normal Volume | Measurement | Increases in |
|---|---|---|---|---|
| Anatomical | Conducting airways (no alveoli) | ~150 mL | Fowler's method | Emphysema (destroyed alveolar walls = fewer/enlarged conducting units; airways enlarge); large tidal volumes |
| Alveolar | Ventilated but unperfused alveoli | ~0 mL (normal) | Bohr's equation minus anatomical DS | Pulmonary embolism, pulmonary hypertension, shock |
| Physiological | Anatomical + Alveolar | ~150 mL | Bohr's equation | Any lung disease (V/Q mismatch) |
Alveolar Ventilation (VA) = (Tidal Volume - Dead Space Volume) × Respiratory Rate
VA = (VT - VD) × RR
VA = (500 - 150) × 12 = 350 × 12 = 4200 mL/min = 4.2 L/min
| Factor | Effect on Dead Space | Mechanism |
|---|---|---|
| ↑ Tidal Volume | ↑ Anatomical DS (slightly) | Airways slightly expand |
| ↑ Age | ↑ Anatomical DS | Loss of airway elastic tissue |
| Emphysema | ↑ Anatomical DS | Destruction of alveolar walls → air sacs coalesce |
| Pulmonary Embolism | ↑ Alveolar + Physiological DS | Loss of perfusion to ventilated alveoli |
| Mechanical ventilation | ↑ Physiological DS | Dead space of ventilator tubing + overdistension of alveoli |
| Upright position | ↑ Alveolar DS (apex of lung) | Gravity pulls blood to lung bases → apex relatively underperfused |
| Supine position | ↓ Alveolar DS | More uniform perfusion |
VA = (Tidal Volume - Dead Space Volume) × Respiratory Rate VA = (VT - VD) × RR
| Q | Options | Answer | Reason |
|---|---|---|---|
| 1. In CO poisoning, arterial PO₂ is: | A) Low B) Normal C) High D) Variable | B | CO displaces O₂ from Hb but dissolved O₂ (PaO₂) is normal - CO doesn't affect dissolved O₂ or lung function |
| 2. Histotoxic hypoxia is caused by: | A) Anaemia B) Heart failure C) High altitude D) Cyanide poisoning | D | Cyanide blocks cytochrome oxidase → cells cannot use O₂ |
| 3. Anatomical dead space in a 70 kg adult: | A) 50 mL B) 100 mL C) 150 mL D) 200 mL | C | ~150 mL (2 mL/kg, or 1 mL/pound body weight) |
| 4. Normal VD/VT ratio at rest: | A) 10% B) 20% C) 30% D) 50% | C | VD/VT = 150/500 = 30% of each tidal breath is dead space |
| 5. Which type of hypoxia has normal PaO₂ AND normal Hb? | A) Hypoxic B) Anaemic C) Stagnant D) Histotoxic | C & D | Stagnant = normal blood, ↓ flow; Histotoxic = normal blood + flow, ↓ cell utilization |
| 6. Polycythaemia in chronic hypoxia is due to: | A) ↑ Thrombopoietin B) ↑ EPO (erythropoietin) C) ↑ 2,3-BPG D) ↑ ADH | B | Renal interstitial cells release EPO in response to low PO₂ → ↑ RBC production |
| 7. Bohr's equation is used to measure: | A) Anatomical dead space B) Physiological dead space C) Tidal volume D) Residual volume | B | Bohr's equation: VD/VT = (PaCO₂ - PECO₂)/PaCO₂ → measures PHYSIOLOGICAL dead space |
| 8. In pulmonary embolism, blood gas shows: | A) ↓ PO₂ + ↑ PaCO₂ B) ↓ PO₂ + ↓ PaCO₂ C) Normal PO₂ + ↑ PaCO₂ D) Normal PO₂ + normal PaCO₂ | B | PE → V/Q mismatch → hypoxaemia (↓ PO₂); hypoxaemia triggers hyperventilation → ↓ PaCO₂ (respiratory alkalosis) |
| 9. Peripheral chemoreceptors for hypoxia are located in: | A) Medulla B) Pons C) Carotid and aortic bodies D) Hypothalamus | C | Carotid bodies (CN IX) and aortic bodies (CN X) are peripheral chemoreceptors sensitive to ↓ PO₂ |
| 10. Alveolar ventilation = | A) VT × RR B) (VT - VD) × RR C) (VT + VD) × RR D) VD × RR | B | VA = (Tidal Volume - Dead Space) × Respiratory Rate |
| # | Topic | Status |
|---|---|---|
| 1 | Cardiac Cycle | ✅ Done |
| 2 | Cardiac Output | ✅ Done |
| 3 | Blood Pressure + Baroreceptors | ✅ Done |
| 4 | ECG | ✅ Done |
| 5 | Shock | ✅ Done |
| 6 | O₂-Hb Dissociation Curve + O₂ Transport + Bohr Effect | ✅ Done |
| 7 | Hypoxia + Dead Space | ✅ Done |
| → 8 | Environmental Physiology: CO Poisoning + Decompression Sickness + High Altitude | Next |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Pending |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13 | GIT | Pending |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
Next (use less credits from now )
Next topic
Next
| Altitude | Barometric Pressure | PO₂ of inspired air (PiO₂) |
|---|---|---|
| Sea level | 760 mmHg | 159 mmHg |
| 3,000 m (10,000 ft) | 523 mmHg | 110 mmHg |
| 5,500 m (18,000 ft - Everest Base) | 380 mmHg | ~80 mmHg |
| 8,848 m (Everest summit) | ~253 mmHg | ~53 mmHg |
↑ Altitude → ↓ PiO₂ → ↓ PAO₂ → ↓ PaO₂
↓
┌──────────────────────────────────────┐
│ IMMEDIATE: Peripheral chemoreceptors │
│ → ↑ Ventilation (but limited by │
│ respiratory alkalosis) │
│ → ↑ HR + ↑ CO │
└──────────────────────────────────────┘
↓ Days
┌──────────────────────────────────────┐
│ Renal HCO₃⁻ excretion │
│ → pH normalises │
│ → Central chemorec. inhibition lifted │
│ → Full ventilatory compensation │
│ + ↑ 2,3-BPG → Right shift O₂-Hb │
└──────────────────────────────────────┘
↓ Weeks
┌──────────────────────────────────────┐
│ ↑ EPO → Polycythaemia │
│ ↑ Capillary density │
│ ↑ Mitochondrial density │
└──────────────────────────────────────┘
Decompression Sickness (DCS) = a condition caused by the formation of gas bubbles in blood and tissues when a person who has been breathing compressed air (at increased pressure) ascends too quickly to a lower pressure environment.
Dissolved gas ∝ Pressure of gas
| Type | Name | Mechanism | Symptoms |
|---|---|---|---|
| Type I (Mild) | The Bends | N₂ bubbles in joints/musculoskeletal | Joint pain (elbows, shoulders, knees), limb pain - "bends" because patient bends over in pain |
| Type I | Skin bends | Bubbles in skin | Pruritus, mottled rash ("cutis marmorata") |
| Type II (Severe) | Chokes | Bubbles in pulmonary vessels | Chest pain, dyspnoea, cough - very serious |
| Type II | Staggers | Bubbles in CNS/vestibular system | Vertigo, nausea, ataxia |
| Type II | Paralysis | Bubbles in spinal cord vasculature | Para/quadriplegia - due to spinal cord ischaemia |
| Type II | Arterial gas embolism | Bubbles in coronary/cerebral arteries | MI, stroke, death |
| COHb % | Symptoms |
|---|---|
| < 10% | Mild headache (or none in non-smokers) |
| 10-20% | Headache, exertional dyspnoea |
| 20-40% | Throbbing headache, nausea, confusion, impaired judgment |
| 40-60% | Convulsions, syncope, tachycardia, hypotension |
| > 60% | Coma, death |
| Feature | CO Poisoning | Cyanide Poisoning |
|---|---|---|
| Mechanism | ↓ Hb O₂ carrying + left shift + cytochrome block | Cytochrome c oxidase block ONLY |
| PaO₂ | Normal | Normal |
| COHb | High | Normal |
| Venous blood | Cherry red (CO-Hb is red) | Cherry red (O₂ not extracted) |
| Pulse ox | Falsely normal | Normal (since PaO₂ normal) |
| Source | House fires, car exhaust | Industrial, house fires, apricot seeds |
| Treatment | 100% O₂, HBO₂ | Hydroxocobalamin, nitrite-thiosulfate |
| Feature | High Altitude | Decompression Sickness | CO Poisoning |
|---|---|---|---|
| Core problem | ↓ O₂ pressure | N₂ bubble formation | COHb + cytochrome block |
| Gas involved | O₂ (deficit) | N₂ (excess dissolved) | CO (binds Hb) |
| Physical law | Dalton's law | Henry's law | Competitive binding |
| Key symptom | Headache, AMS | Joint pain (bends) | Headache, cherry-red skin |
| Brain complication | HACE | CNS bubbles (staggers) | Encephalopathy, delayed neuropsych |
| Lung complication | HAPE | Chokes (pulmonary emboli) | Pulmonary oedema (severe) |
| Treatment | Descend + O₂ + acetazolamide | Hyperbaric O₂ | 100% O₂ (±hyperbaric) |
| Q | Answer | Key Reason |
|---|---|---|
| 1. Henry's law is the basis for: | Decompression sickness | Dissolved gas ∝ pressure |
| 2. Half-life of COHb breathing 100% O₂: | 60-90 min | vs 4-5 hrs on room air |
| 3. First line treatment for HAPE: | Descent + O₂ + Nifedipine | Nifedipine dilates pulmonary vessels |
| 4. Acetazolamide prevents AMS by: | Inhibiting carbonic anhydrase → renal HCO₃⁻ loss → metabolic acidosis → ↑ ventilation | Speeds up acclimatization |
| 5. CO affinity for Hb compared to O₂: | 240 times greater | Competes for O₂ binding sites |
| 6. Nitrogen narcosis occurs at depths > : | 30-40 metres | N₂ dissolves in neuronal membranes |
| 7. Polycythaemia at altitude is due to: | ↑ EPO from kidneys | Response to ↓ PaO₂ |
| 8. Pulse oximetry is unreliable in: | CO poisoning | COHb absorbs same wavelength as OxyHb |
| 9. Most dangerous altitude illness: | HAPE (leading cause of altitude death) | Pulmonary oedema, rapidly fatal |
| 10. Treatment of HACE includes: | Descent + O₂ + Dexamethasone | Dexamethasone reduces vasogenic oedema |
| # | Topic | Status |
|---|---|---|
| 1-7 | CVS + Respiratory (completed) | ✅ |
| 8 | Environmental Physiology | ✅ Done |
| → 9 | Thyroid Hormones + Hypo/Hyperthyroidism | Next |
| 10 | Glucocorticoids + Cushing's | Pending |
| 11 | Insulin + DM | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13-18 | GIT, Bilirubin, Temp, Exercise, Pituitary, AETCOM | Pending |
Next
Dietary Iodide (I⁻)
↓
NIS symporter (TSH-stimulated)
↓
I⁻ in follicular cell
↓
TPO + H₂O₂ → I₂ (oxidation)
↓
Tg (thyroglobulin, tyrosine-rich)
secreted into colloid lumen
↓
TPO catalyses iodination:
Tg-Tyr + I₂ → MIT, DIT (organification)
↓
DIT + DIT → T4 (on Tg)
DIT + MIT → T3 (on Tg) (coupling)
↓
Storage as thyroglobulin-T3/T4 in colloid
↓
TSH → pinocytosis → lysosomal proteolysis
↓
T3 and T4 released into blood
↓
MIT + DIT → recycled (deiodinase)
BLOOD SIDE FOLLICULAR CELL COLLOID LUMEN
──────────── ─────────────────── ─────────────
I⁻ in blood → NIS (Na⁺/I⁻ symporter) → Tg (thyroglobulin)
[basolateral] |
TSH → adenylyl TPO enzyme | iodination
cyclase → cAMP [apical membrane] → MIT, DIT on Tg
|
T3, T4 released ← lysosomal proteolysis ← Tg-T3/T4 endocytosed
into blood of Tg
|
MIT+DIT → iodine ← recycled
recycled by deiodinase
| Feature | T4 | T3 |
|---|---|---|
| Amount secreted by thyroid | 90% | 10% |
| Plasma level | Higher | Lower (but more potent) |
| Protein binding | 99.97% bound | 99.7% bound |
| Free (active) fraction | 0.03% | 0.3% |
| Potency | Less potent (prodrug) | 3-5× more potent |
| Half-life | 7 days (long - due to tight TBG binding) | 1 day (short) |
| Source | Thyroid gland (direct) | 20% thyroid + 80% from T4 deiodination in peripheral tissues |
| System | Effect | Mechanism |
|---|---|---|
| Basal Metabolic Rate (BMR) | ↑ BMR (most important action) | ↑ O₂ consumption, ↑ heat production, ↑ mitochondrial activity |
| Carbohydrates | ↑ Glucose absorption from gut; ↑ glycogenolysis; ↑ gluconeogenesis; ↑ glucose oxidation | Net effect: Slightly ↑ blood glucose |
| Proteins | Low dose: Anabolic (↑ protein synthesis for growth) | High dose: Catabolic (↑ proteolysis → muscle wasting, negative nitrogen balance) |
| Fats | ↑ Lipolysis; ↑ lipid oxidation; ↓ cholesterol (↑ LDL receptor expression) | Hyperthyroid: ↓ serum cholesterol; Hypothyroid: ↑ serum cholesterol |
| Heat production | Calorigenic effect - ↑ thermogenesis by uncoupling of oxidative phosphorylation | Makes the patient feel hot in hyperthyroidism |
| Effect | Importance |
|---|---|
| Essential for normal CNS development (prenatal + postnatal) | Deficiency → Cretinism (intellectual disability, deaf-mutism) |
| Permissive for GH action | TH must be present for GH to exert full growth-promoting effects; hypothyroid child is short |
| Stimulates bone maturation | Promotes ossification and bone age advancement |
| Synergizes with GH for longitudinal growth |
| System | TH Action |
|---|---|
| GIT | ↑ gut motility → diarrhoea in hyperthyroidism; constipation in hypothyroidism |
| Muscle | Normal function; hypothyroid → myopathy, pseudohypertrophy |
| Skin | Thin, warm, moist in hyperthyroid; dry, coarse, cold in hypothyroid |
| Haematopoiesis | ↑ EPO production → ↑ RBC mass |
| Respiratory | ↑ respiratory rate (to meet ↑ O₂ demand) |
HYPOTHALAMUS
↓ TRH (Thyrotropin-Releasing Hormone)
(tripeptide; Glu-His-Pro)
ANTERIOR PITUITARY
↓ TSH (Thyroid-Stimulating Hormone)
(glycoprotein; α + β subunits)
THYROID GLAND
↓ T3 + T4
PERIPHERAL TISSUES
(T4 → T3 conversion)
↓
NEGATIVE FEEDBACK:
T3/T4 ↑ → inhibits TRH (at hypothalamus)
→ inhibits TSH (at pituitary)
→ TSH falls → T3/T4 production falls → homeostasis
| Factor | Effect on TSH/TRH |
|---|---|
| ↑ T3/T4 | ↓ TRH and TSH (negative feedback) |
| Cold exposure | ↑ TRH → ↑ TSH → ↑ T3/T4 (↑ thermogenesis) |
| Somatostatin | ↓ TSH |
| Dopamine | ↓ TSH |
| Oestrogen | ↑ TRH sensitivity → ↑ TSH |
| Type | Level | Cause |
|---|---|---|
| Primary (most common, 95%) | Thyroid gland fails | Hashimoto's thyroiditis (autoimmune, anti-TPO Ab), post-thyroidectomy, radioiodine therapy, iodine deficiency |
| Secondary | Pituitary fails | ↓ TSH (pituitary adenoma, Sheehan's) |
| Tertiary | Hypothalamus fails | ↓ TRH |
| Congenital | Multiple | Aplasia/dysplasia of thyroid, enzyme defects |
| System | Feature | Mechanism |
|---|---|---|
| General | Weight gain, cold intolerance, fatigue, lethargy | ↓ BMR |
| CVS | Bradycardia, ↓ CO, ↑ diastolic BP, cardiomegaly, pericardial effusion | ↓ β-receptor expression + ↓ cardiac TH effects |
| Skin | Dry, coarse, cold, pale skin; non-pitting oedema (myxoedema) | Accumulation of glycosaminoglycans in dermis (not fluid - hence non-pitting) |
| Hair/Nails | Dry brittle hair, hair loss, loss of lateral 1/3 of eyebrow (Queen Anne's sign) | ↓ TH trophic effects |
| Neurology | Slow mentation, depression, psychosis ("myxoedema madness"), delayed relaxation phase of reflexes | ↓ nervous system activity |
| GIT | Constipation, ↑ weight | ↓ gut motility |
| Reproductive | Menorrhagia (heavy periods), anovulation, infertility | ↑ TRH → ↑ prolactin → hyperprolactinaemia → anovulation |
| Musculoskeletal | Muscle stiffness, myalgia, pseudohypertrophy of muscles (Kocher-Debre-Semelaigne syndrome in children) | ↓ protein synthesis + glycosaminoglycan accumulation |
| Lipids | ↑ Total cholesterol, ↑ LDL | ↓ LDL receptor expression |
| Cause | Mechanism |
|---|---|
| Graves' disease (most common, 80%) | Autoimmune - TSH receptor antibodies (TRAb) stimulate TSH receptor continuously → unregulated T3/T4 production |
| Toxic multinodular goitre | Autonomous nodules produce excess T3/T4 independent of TSH |
| Toxic adenoma (Plummer's disease) | Single autonomous adenoma |
| Thyroiditis (subacute, Hashimoto's) | Inflammation → stored hormone released acutely → transient hyperthyroid phase |
| Exogenous | Over-replacement with levothyroxine |
| System | Feature |
|---|---|
| General | Weight loss despite ↑ appetite, heat intolerance, sweating, fever |
| CVS | Tachycardia, palpitations, atrial fibrillation (most serious cardiac complication), widened pulse pressure, ↑ CO |
| Neurology | Anxiety, restlessness, tremor (fine tremor), insomnia, emotional lability, hyperreflexia |
| Eyes (Graves') | Exophthalmos, lid lag (von Graefe sign), lid retraction (Dalrymple sign), stare |
| GIT | Diarrhoea, ↑ appetite but weight loss |
| Reproductive | Oligomenorrhoea/amenorrhoea in women (anovulation from disrupted LH surge) |
| Skin | Warm, moist, smooth skin; pretibial myxoedema (Graves') |
| Muscle | Proximal myopathy, weakness |
| Bone | ↑ Bone turnover → osteoporosis (chronic hyperthyroidism) |
| Metabolic | ↑ BMR → heat intolerance, sweating |
| Feature | Hypothyroidism | Hyperthyroidism |
|---|---|---|
| Weight | ↑ (despite ↓ appetite) | ↓ (despite ↑ appetite) |
| BMR | ↓ | ↑ |
| Temperature | Cold intolerance, hypothermia | Heat intolerance, fever |
| Heart rate | Bradycardia | Tachycardia, AF |
| Reflexes | Delayed (slow relaxation) | Hyperreflexia |
| Skin | Dry, coarse, cold | Warm, moist, smooth |
| Hair | Dry, brittle, falling | Fine, silky |
| Bowel | Constipation | Diarrhoea |
| Mood | Depression, slow mentation | Anxiety, agitation |
| Cholesterol | ↑ LDL | ↓ |
| TSH | ↑ (primary); ↓ (secondary) | ↓ (primary/Graves') |
| Oedema | Non-pitting myxoedema | Pretibial myxoedema (Graves') |
| Classic cause | Hashimoto's | Graves' disease |
| Drug | Mechanism | Special Feature |
|---|---|---|
| Propylthiouracil (PTU) | Blocks TPO (blocks organification + coupling) + also blocks T4→T3 conversion (peripheral) | Preferred in pregnancy (1st trimester), thyroid storm |
| Carbimazole / Methimazole | Blocks TPO only (no peripheral effect) | Drug of choice for long-term treatment; SE: agranulocytosis (check WBC if fever/sore throat) |
| Radioactive iodine (¹³¹I) | Destroys thyroid follicular cells by beta radiation | Contraindicated in pregnancy |
| Lugol's iodine | Wolff-Chaikoff effect → ↓ organification + ↓ hormone release | Pre-surgical preparation |
| Beta-blockers (propranolol) | Blocks adrenergic symptoms + ↓ peripheral T4→T3 | Adjunct, immediate symptom relief |
| Q | Answer | Key Point |
|---|---|---|
| 1. T4 is converted to active T3 in peripheral tissues by: | 5'-deiodinase | T4 is a prohormone |
| 2. Thyroid peroxidase antibodies are diagnostic of: | Hashimoto's thyroiditis | Anti-TPO Ab |
| 3. Most abundant thyroid hormone in circulation: | T4 | 90% of secretion is T4 |
| 4. Most potent thyroid hormone: | T3 | 3-5× more potent than T4 |
| 5. Half-life of T4: | 7 days | Long half-life (why levothyroxine is once daily) |
| 6. Non-pitting oedema in hypothyroidism is due to: | Glycosaminoglycan accumulation | NOT fluid oedema |
| 7. Drug preferred in thyroid storm AND pregnancy: | PTU | Also blocks peripheral T4→T3 |
| 8. Exophthalmos in Graves' disease is due to: | Retroorbital autoimmune inflammation | Not TH excess (persists after treatment) |
| 9. Cretinism is caused by: | Congenital/infantile hypothyroidism | Irreversible if not treated early |
| 10. Wolff-Chaikoff effect is: | High iodine → transiently inhibits organification | Basis of pre-op Lugol's iodine |
| # | Topic | Status |
|---|---|---|
| 1-8 | CVS + Respiratory + Environmental | ✅ |
| 9 | Thyroid Hormones + Hypo/Hyperthyroidism | ✅ Done |
| → 10 | Glucocorticoids + Cushing's Syndrome | Next |
| 11 | Insulin + Diabetes Mellitus | Pending |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13-18 | GIT, Bilirubin, Temp, Exercise, Pituitary, AETCOM | Pending |
Next
| Zone | Name | Hormone Secreted | Mnemonic |
|---|---|---|---|
| Outer (Glomerulosa) | Zona Glomerulosa | Mineralocorticoids (Aldosterone) | Goes = Glomerulosa → aldosterone |
| Middle (Fasciculata) | Zona Fasciculata | Glucocorticoids (Cortisol) - largest zone | Fasciculata → cortisol |
| Inner (Reticularis) | Zona Reticularis | Androgens (DHEA, androstenedione) | Reticularis → sex steroids |
| Adrenal medulla | (Not cortex) | Catecholamines (adrenaline, noradrenaline) | Modified sympathetic ganglion |
HYPOTHALAMUS
↓ CRH (Corticotropin-Releasing Hormone)
Pulsatile; peak in early morning
ANTERIOR PITUITARY (Corticotroph cells)
↓ ACTH (Adrenocorticotropic Hormone)
Peptide; cleaved from POMC (pro-opiomelanocortin)
ADRENAL CORTEX (Zona Fasciculata)
↓ CORTISOL
NEGATIVE FEEDBACK:
Cortisol → inhibits CRH (hypothalamus) + ACTH (pituitary)
| Action | Effect |
|---|---|
| ↑ Gluconeogenesis (liver) | Makes new glucose from amino acids, glycerol, lactate |
| ↑ Glycogen synthesis (liver) | Stores glucose as glycogen in liver |
| ↓ Peripheral glucose uptake | Inhibits GLUT-4 translocation in muscle and fat → insulin resistance |
| ↑ Blood glucose | Net effect → hyperglycaemia → "steroid diabetes" |
| Action | Effect |
|---|---|
| ↑ Protein catabolism in muscle | Releases amino acids (substrates for gluconeogenesis) |
| ↑ Amino acid uptake by liver | Feeds gluconeogenesis |
| ↓ Protein synthesis in peripheral tissues | Negative nitrogen balance |
| Clinical effects | Muscle wasting, skin thinning, poor wound healing, striae, osteoporosis (↓ bone matrix protein) |
| Action | Effect |
|---|---|
| ↑ Lipolysis in extremities | Releases free fatty acids → fuel for gluconeogenesis |
| ↑ Fat deposition in trunk, face, neck | Redistribution (not fully explained - insulin-mediated fat deposition at trunk?) |
| Clinical result | Central obesity, moon face, buffalo hump - the classic Cushing's appearance |
| Mechanism | Effect |
|---|---|
| ↑ Lipocortin (annexin-1) synthesis | Inhibits phospholipase A₂ → ↓ arachidonic acid release → ↓ prostaglandins + leukotrienes |
| ↓ COX-2 expression | ↓ Prostaglandin synthesis |
| ↓ Cytokine production | ↓ IL-1, IL-2, IL-6, TNF-α → ↓ fever, inflammation |
| ↓ Capillary permeability | Stabilizes vascular endothelium → ↓ oedema |
| ↓ Neutrophil migration | ↑ Neutrophil count in blood (neutrophilia) but ↓ their movement to sites of infection |
| Lymphocyte apoptosis | ↓ Lymphocytes, eosinophils in blood |
| ↓ Antibody production | ↓ B cell function at high doses |
| System | Action |
|---|---|
| Lungs | Essential for fetal lung maturation (↑ surfactant synthesis) - antenatal steroids given in premature labour |
| CNS | ↑ Mood and arousal (low-moderate levels); high levels → depression, psychosis, cognitive impairment |
| Haematology | ↑ RBC production, ↑ neutrophils, ↓ lymphocytes, ↓ eosinophils |
| Growth | High levels → ↓ GH secretion + inhibit growth plate → growth retardation in children |
| Gastric mucosa | ↓ Mucus secretion → ↑ peptic ulcer risk (especially with NSAIDs) |
| Eye | Chronic use → posterior subcapsular cataract, glaucoma |
GLUCOCORTICOIDS (Cortisol)
|
┌──────┼──────────┬────────────┬──────────┐
↓ ↓ ↓ ↓ ↓
METABOLIC ANTI-INFLAM CVS BONE CNS/OTHER
↑glucose ↓PGs/LTs BP mainten. Osteoporosis ↑mood
↑gluconeo ↓cytokines ↑cardiac ↓osteoblast lung mat.
catabolic neutrophilia output ↑osteoclast immunosupp
fat redis ↓lymphocytes hypertension fractures peptic ulcer
Cushing's Syndrome: The clinical state resulting from chronic exposure to excess glucocorticoids (cortisol), from any cause.
Cushing's Disease (more specific): Cushing's syndrome caused specifically by an ACTH-secreting pituitary adenoma (named after Harvey Cushing, the neurosurgeon who first described it).
| Cause | % | Details |
|---|---|---|
| Cushing's Disease (pituitary adenoma) | 70% | ACTH-secreting corticotroph microadenoma, usually < 1 cm; most common non-iatrogenic cause |
| Ectopic ACTH syndrome | 10% | ACTH secreted by non-pituitary tumour - small cell lung cancer (most common), carcinoid tumours, medullary thyroid Ca, phaeochromocytoma |
| Cause | % | Details |
|---|---|---|
| Iatrogenic (exogenous steroids) | Most common overall cause | Long-term corticosteroid therapy for asthma, RA, IBD, organ transplant |
| Adrenal adenoma | 10% | Benign adrenal tumour secreting cortisol autonomously |
| Adrenal carcinoma | Rare | Usually large tumour; may co-secrete androgens |
| Adrenal hyperplasia (bilateral) | Rare | PPNAD, AIMAH |
HEAD: Moon face (round, plethoric face), acne
Exophthalmos not present (unlike Graves')
NECK: Buffalo hump (fat pad over posterior neck/upper back)
Supraclavicular fat pads
TRUNK: Central obesity (truncal fat)
Wide purple striae (stretch marks) on abdomen, flanks
(purple = thin skin + underlying vasculature visible)
LIMBS: Muscle wasting + proximal muscle weakness (thin arms/legs)
Peripheral fat loss (lemon-on-sticks appearance)
SKIN: Thin, fragile skin; easy bruising (ecchymoses)
Poor wound healing
Hirsutism (excess androgens from reticularis)
BONE: Osteoporosis → vertebral fractures, height loss
BP: Hypertension
GLUCOSE: Hyperglycaemia (steroid diabetes)
| Feature | Mechanism |
|---|---|
| Central obesity + moon face + buffalo hump | ↑ Fat deposition centrally (↑ gluconeogenesis, altered fat redistribution) |
| Proximal muscle weakness | ↑ Protein catabolism → muscle wasting |
| Wide purple striae | Skin thinning (↓ collagen) + central fat stretches skin → vessels visible = purple |
| Easy bruising / thin skin | ↓ Collagen synthesis (↓ skin structural proteins) |
| Hypertension | Na⁺ retention (mineralocorticoid effect of high cortisol) + ↑ vascular reactivity |
| Hyperglycaemia | ↑ Gluconeogenesis + insulin resistance |
| Osteoporosis | ↓ Bone formation + ↓ Ca²⁺ absorption |
| Poor wound healing / infections | Immunosuppression + ↓ collagen |
| Hirsutism + acne (in women) | Excess androgens from zona reticularis co-stimulated by ACTH |
| Amenorrhoea | High cortisol suppresses GnRH → ↓ LH/FSH → anovulation |
| Psychiatric symptoms | Direct CNS effects of cortisol: depression, mania, cognitive impairment |
| Hyperpigmentation (only in ACTH-dependent) | Excess ACTH (contains MSH sequence) → stimulates melanocytes |
| Test | Method | Interpretation |
|---|---|---|
| 24-hour urinary free cortisol (UFC) | Urine collection | ↑ UFC > 3-4× upper limit = significant hypercortisolism |
| Late-night salivary cortisol | Saliva at midnight | Should be lowest at midnight; elevated = lost diurnal rhythm |
| Overnight 1 mg dexamethasone suppression test (DST) | Give 1 mg dexamethasone at 11 PM; measure 8 AM cortisol | Normal: cortisol < 1.8 µg/dL (suppressed); Cushing's: fails to suppress |
| ACTH Level | Interpretation | Next Step |
|---|---|---|
| Low ACTH (< 5 pg/mL) | ACTH-independent → adrenal cause | CT/MRI of adrenal glands |
| High/Normal ACTH (> 15 pg/mL) | ACTH-dependent → pituitary or ectopic | MRI pituitary |
| If MRI pituitary negative | Can't exclude Cushing's disease | IPSS (inferior petrosal sinus sampling) - gold standard |
| Test | Pituitary (Cushing's Disease) | Ectopic ACTH |
|---|---|---|
| High-dose DST (8 mg overnight) | Suppresses (pituitary retains some feedback sensitivity) | Does NOT suppress (tumour independent) |
| CRH stimulation test | ACTH + cortisol rise (pituitary responds) | Minimal response |
| IPSS (gold standard) | Central:peripheral ACTH ratio > 3:1 after CRH = pituitary | Ratio < 3 = ectopic |
| Cause | Treatment |
|---|---|
| Cushing's Disease (pituitary adenoma) | Trans-sphenoidal surgery (first-line); radiotherapy if surgery fails; adrenalectomy (bilateral) as last resort |
| Adrenal adenoma | Unilateral adrenalectomy |
| Ectopic ACTH | Treat primary tumour; ketoconazole/metyrapone to block cortisol synthesis |
| Iatrogenic | Gradually taper steroids (never abrupt withdrawal - risk of adrenal crisis) |
Primary adrenocortical insufficiency due to destruction or dysfunction of the adrenal cortex, resulting in deficiency of all three classes of adrenocortical hormones.
| Deficiency | Features |
|---|---|
| Glucocorticoid (↓ cortisol) | Fatigue, weakness, hypoglycaemia, inability to handle stress, anorexia, weight loss, nausea |
| Mineralocorticoid (↓ aldosterone) | Na⁺ loss → hyponatraemia; K⁺ retention → hyperkalaemia; ↓ blood pressure, postural hypotension, salt craving |
| Androgen (↓ DHEA) | Loss of pubic and axillary hair (esp. in women who rely on adrenal androgens) |
| ↑↑ ACTH (compensatory) | Hyperpigmentation - buccal mucosa, palmar creases, scars, pressure points, genitalia |
| Feature | Cushing's (Excess) | Addison's (Deficiency) |
|---|---|---|
| Cortisol | ↑↑ | ↓↓ |
| ACTH | ↑ (if ACTH-dep) or ↓ (if adrenal) | ↑↑ (all primary Addison's) |
| Weight | ↑ (central obesity) | ↓ (weight loss) |
| Blood pressure | ↑ | ↓ (postural hypotension) |
| Blood glucose | ↑ (steroid diabetes) | ↓ (hypoglycaemia) |
| Na⁺ | Normal or ↑ | ↓ (hyponatraemia) |
| K⁺ | ↓ (hypokalaemia) | ↑ (hyperkalaemia) |
| Skin | Thin, purple striae, plethoric face | Hyperpigmentation |
| Muscle | Proximal weakness (wasted) | Weakness (no energy) |
| Bones | Osteoporosis | Normal |
| Mood | Psychosis, mania, depression | Depression, anxiety |
| Q | Answer | Key Point |
|---|---|---|
| 1. Zona fasciculata secretes: | Glucocorticoids (cortisol) | GFR mnemonic |
| 2. Cushing's DISEASE specifically means: | ACTH-secreting pituitary adenoma | Disease = pituitary; Syndrome = any cause |
| 3. Most common overall cause of Cushing's syndrome: | Iatrogenic (exogenous steroids) | NOT pituitary adenoma |
| 4. High-dose dexamethasone suppresses cortisol in: | Cushing's disease (pituitary) | Ectopic ACTH does not suppress |
| 5. Hyperpigmentation in Addison's is due to: | ↑ ACTH/MSH from POMC | ACTH and MSH share peptide sequence |
| 6. Purple striae in Cushing's differ from pregnancy striae: | Purple/wide vs pink/narrow | Cortisol → thin skin + vessel visibility |
| 7. Antenatal glucocorticoids are given to: | Promote fetal lung surfactant maturation | Betamethasone/dexamethasone given in preterm labour |
| 8. First step in diagnosis of Cushing's: | 24-hr UFC or overnight DST | Confirm hypercortisolism first, then find source |
| 9. Treatment of adrenal crisis: | IV hydrocortisone 100 mg + IV saline | Never delay for investigations |
| 10. Drug that inhibits 11β-hydroxylase (cortisol synthesis): | Metyrapone | Used medically for Cushing's |
| # | Topic | Status |
|---|---|---|
| 1-9 | CVS, Respiratory, Environmental, Thyroid | ✅ |
| 10 | Glucocorticoids + Cushing's + Addison's | ✅ Done |
| → 11 | Insulin + Diabetes Mellitus | Next |
| 12 | Menstrual Cycle + Spermatogenesis | Pending |
| 13-18 | GIT, Bilirubin, Temp, Exercise, Pituitary, AETCOM | Pending |
Next
| Cell Type | % | Hormone | Function |
|---|---|---|---|
| β (Beta) cells | 60-70% | Insulin | ↓ Blood glucose |
| α (Alpha) cells | 20-25% | Glucagon | ↑ Blood glucose |
| δ (Delta) cells | 5-10% | Somatostatin | Inhibits both insulin + glucagon |
| PP cells | ~5% | Pancreatic polypeptide | Regulates exocrine pancreas |
↑ Blood glucose
↓
Glucose enters β cell via GLUT-2 (facilitated diffusion)
↓
Glucokinase (hexokinase IV) phosphorylates → Glucose-6-phosphate
↓
Glycolysis + oxidative phosphorylation → ↑ ATP synthesis
↓
↑ ATP:ADP ratio
↓
ATP-sensitive K⁺ channels (KATP) CLOSE
↓
K⁺ cannot leave cell → membrane DEPOLARIZES
↓
Voltage-gated Ca²⁺ channels OPEN
↓
Ca²⁺ enters β cell
↓
Exocytosis of insulin granules → Insulin released into blood
| Stimulus | Effect | Notes |
|---|---|---|
| ↑ Blood glucose | Major stimulus | Glucose is the primary physiological stimulus |
| Amino acids (arginine, leucine) | ↑ Insulin | This is why protein meal also stimulates insulin |
| GIP + GLP-1 (incretins) | ↑ Insulin | Gut hormones released after oral glucose; explain why oral glucose → more insulin than IV glucose (incretin effect) |
| Glucagon | ↑ Insulin | Paracrine stimulation |
| Vagal (parasympathetic) stimulation | ↑ Insulin | Cephalic phase: sight/smell of food → insulin rises before eating |
| β2-adrenergic stimulation | ↑ Insulin | Adrenaline has dual effects |
| Sulphonylureas | ↑ Insulin | Drug-induced (close KATP) |
| Somatostatin | ↓ Insulin | Paracrine inhibition from δ cells |
| α2-adrenergic stimulation | ↓ Insulin | Adrenaline dominantly INHIBITS insulin via α2 (fight-or-flight: don't waste insulin during stress) |
| Fasting/hypoglycaemia | ↓ Insulin | Physiological |
| Action | Tissue | Effect |
|---|---|---|
| ↑ Glucose uptake | Muscle, adipose tissue | ↑ GLUT-4 translocation to membrane → glucose entry |
| ↑ Glycogen synthesis | Liver, muscle | ↑ Glycogen synthase → stores glucose |
| ↓ Glycogenolysis | Liver | ↓ Glycogen phosphorylase |
| ↓ Gluconeogenesis | Liver | ↓ PEPCK, glucose-6-phosphatase → less new glucose made |
| ↑ Glycolysis | Liver, muscle | ↑ Glucose oxidation for energy |
| Net effect | All | ↓ Blood glucose |
| Action | Effect |
|---|---|
| ↑ Fatty acid synthesis in liver | Glucose → acetyl-CoA → fatty acids |
| ↑ Triglyceride storage in adipose | ↑ Lipoprotein lipase (LPL) → TGs taken up from blood + stored |
| ↓ Lipolysis | ↓ Hormone-sensitive lipase (HSL) → fat stays in adipocytes |
| ↓ Ketogenesis | ↓ FFA supply to liver → ↓ ketone bodies |
| Action | Effect |
|---|---|
| ↑ Amino acid uptake by cells | Facilitates AA transport into muscle |
| ↑ Protein synthesis | ↑ mRNA translation |
| ↓ Protein catabolism | Opposes glucocorticoid catabolic effects |
| Net effect | Anabolic - muscle building |
INSULIN (Fed state / ↑ blood glucose)
|
┌────────┼────────────┬──────────────┐
↓ ↓ ↓ ↓
GLUCOSE FAT PROTEIN K⁺
↓BG ↑storage ↑synthesis K⁺ into cells
↑GLUT4 ↓lipolysis ↓catabolism ↓serum K⁺
↑glycogen ↓ketones ↑AA uptake
↓gluconeo ↑LPL
Diabetes mellitus (DM) is a group of metabolic disorders characterized by chronic hyperglycaemia resulting from defects in insulin secretion, insulin action, or both, leading to disturbances of carbohydrate, fat, and protein metabolism.
| Feature | Type 1 | Type 2 |
|---|---|---|
| Mechanism | Autoimmune β-cell destruction | Insulin resistance + β-cell failure |
| Insulin level | Absent/very low | Initially ↑, later ↓ |
| Onset | Acute, sudden (days-weeks) | Insidious (years) |
| Age | Typically young (<30) | Typically >40 |
| BMI | Normal/thin | Obese (central) |
| DKA risk | HIGH | Low (rare) |
| HHS risk | Low | HIGH |
| Autoantibodies | Present (anti-GAD, ICA) | Absent |
| HLA association | DR3/DR4 | None |
| C-peptide | Low/absent | Normal/high |
| Treatment | Insulin mandatory | Lifestyle + OHA; insulin later |
| Ketosis | Prone to ketosis | Usually ketosis-resistant |
| Test | Normal | Pre-diabetes | Diabetes |
|---|---|---|---|
| Fasting plasma glucose | < 100 mg/dL | 100-125 mg/dL (IFG) | ≥ 126 mg/dL |
| 2-hr post 75g OGTT | < 140 mg/dL | 140-199 mg/dL (IGT) | ≥ 200 mg/dL |
| Random glucose | - | - | ≥ 200 mg/dL + symptoms |
| HbA1c | < 5.7% | 5.7-6.4% | ≥ 6.5% |
| Complication | Organ | Mechanism | Features |
|---|---|---|---|
| Diabetic nephropathy | Kidney | ↑ Glucose → ↑ mesangial matrix → glomerulosclerosis (Kimmelstiel-Wilson nodules) | Proteinuria → nephrotic syndrome → CKD → ESRD |
| Diabetic retinopathy | Eye | Pericyte loss → microaneurysms → haemorrhages; new vessel formation (proliferative) | Background → pre-proliferative → proliferative → blindness. Leading cause of blindness in working-age adults |
| Diabetic neuropathy | Nerves | Sorbitol pathway (aldose reductase) + AGE formation → axonal degeneration | Peripheral: Glove-and-stocking sensory loss; Autonomic: postural hypotension, gastroparesis, erectile dysfunction |
| Complication | Notes |
|---|---|
| Coronary artery disease | Leading cause of death in DM; often silent (painless MI due to autonomic neuropathy) |
| Stroke | 2-4× higher risk than non-diabetics |
| Peripheral arterial disease | Claudication → gangrene → amputation |
| Diabetic foot | Peripheral neuropathy + PAD + infection → ulcers → osteomyelitis → amputation |
Chronic Hyperglycaemia
↓
┌────────┴────────────────┐
↓ ↓
Polyol pathway Non-enzymatic glycation
(↑ Aldose reductase Glucose + protein → AGEs
→ Sorbitol accumulates (Advanced glycation end-products)
→ osmotic damage → vessel wall damage
→ nerve damage) → ↑ inflammation + fibrosis
↓ ↓
Neuropathy Nephropathy + Retinopathy
+ Atherosclerosis
| Feature | DKA (Type 1) | HHS (Type 2) |
|---|---|---|
| Age | Young | Elderly |
| Onset | Hours to days | Days to weeks |
| Blood glucose | Moderate elevation (~300-600) | Very high (> 600 mg/dL) |
| Ketones | High (++++) | Absent/trace (residual insulin prevents ketosis) |
| pH | Low (acidosis) | Normal |
| Osmolality | Mildly elevated | Very high (> 320 mOsm/kg) |
| Consciousness | Variably altered | Often comatose |
| Dehydration | Moderate | Severe |
| Treatment | Insulin + fluids | Fluids first (gradual rehydration), then insulin |
| Q | Answer | Key Point |
|---|---|---|
| 1. GLUT-4 is present in: | Muscle and adipose tissue (insulin-dependent) | NOT in brain or RBCs |
| 2. Sulphonylureas act by: | Closing ATP-sensitive K⁺ (KATP) channels in β cells | → Depolarization → Ca²⁺ entry → insulin release |
| 3. C-peptide is: | Equimolar with insulin; longer half-life; absent in exogenous insulin | Used to assess β-cell function |
| 4. DKA is characterized by: | ↑ Anion gap metabolic acidosis + ketones | Anion gap = Na⁺ - (Cl⁻ + HCO₃⁻), normal 8-12 |
| 5. HbA1c reflects blood glucose over: | 2-3 months (RBC lifespan) | Not affected by recent meals |
| 6. Insulin receptor type: | Tyrosine kinase receptor | NOT cAMP-mediated |
| 7. Kussmaul breathing in DKA is: | Deep, rapid breathing to compensate metabolic acidosis | Blows off CO₂ to raise pH |
| 8. Fasting glucose diagnostic for DM: | ≥ 126 mg/dL (on two occasions) | Pre-diabetes: 100-125 mg/dL |
| 9. In DKA, serum K⁺ is high but: | Total body K⁺ is DEPLETED | Must replace K⁺ with insulin therapy |
| 10. Incretin hormones are: | GIP and GLP-1 (from gut) | Responsible for 50-70% of insulin response to oral glucose |
| # | Topic | Status |
|---|---|---|
| 1-10 | CVS, Respiratory, Environmental, Thyroid, Glucocorticoids | ✅ |
| 11 | Insulin + Diabetes Mellitus | ✅ Done |
| → 12 | Menstrual Cycle + Spermatogenesis | Next |
| 13-18 | GIT, Bilirubin, Temp, Exercise, Pituitary, AETCOM | Pending |
Next
DIAGRAM: Hormone levels through the 28-day cycle
Day: 1 5 9 13 14 18 22 28
|____|____|____|____|___|____|____|
↑
Ovulation (Day 14)
FSH: ↑(early)→ gradual fall → small surge at Day 13 → falls
[Peaks Day 3-5 follicular phase]
LH: Low → gradually rises → **HUGE SURGE** at Day 12-14 → falls
[LH surge = diagnostic of impending ovulation]
Oestrogen: Low → gradually rises (follicular) → **1st PEAK** Day 12-13
(pre-ovulatory peak) → slight dip → 2nd smaller peak (Day 21)
(luteal phase oestrogen from corpus luteum) → falls Day 26-28
Progesterone: Near zero (follicular phase) → rises after ovulation
→ **PEAK Day 21-22** (luteal phase) → falls Day 26-28
ENDOMETRIUM (height):
Day 1-5: Thin (menstruation, shedding)
Day 6-13: Grows (proliferative) - oestrogen-driven
Day 14-28: Thick + secretory - progesterone-driven
Day 28→1: Sheds again (menstruation)
| Hormone | Source | Key Actions |
|---|---|---|
| GnRH | Hypothalamus | Pulsatile; stimulates FSH + LH from pituitary; continuous GnRH paradoxically INHIBITS (downregulates receptors) |
| FSH | Anterior pituitary | Follicle growth; aromatase in granulosa cells; ↑ LH receptors on granulosa |
| LH | Anterior pituitary | Androgen synthesis by theca; ovulation trigger (LH surge); corpus luteum maintenance |
| Oestrogen (E₂) | Granulosa cells | Endometrial proliferation; ↑ progesterone receptors; LH surge (positive feedback); thin cervical mucus; secondary sexual characters |
| Progesterone | Corpus luteum | Endometrial secretory change; thick cervical mucus; ↑ body temperature; maintains early pregnancy; inhibits uterine contractions |
| Inhibin | Granulosa cells (B in follicular, A in luteal) | Specific negative feedback on FSH |
| hCG | Trophoblast | Rescues corpus luteum; measured in pregnancy test |
SEMINIFEROUS TUBULE WALL (basement membrane to lumen)
Basement membrane
|
Spermatogonia (Type A: stem cells → self-renew)
| Mitosis
Spermatogonia (Type B)
| (Enter meiosis)
Primary spermatocytes (2N, 46 chr) ← LARGEST cells in seminiferous tubule
| Meiosis I (~22 days in prophase)
Secondary spermatocytes (N, 23 chr) ← SHORT-LIVED (hours to day)
| Meiosis II
Spermatids (N, 23 chr, round)
| Spermiogenesis (morphological transformation)
Spermatozoa (mature, N, 23 chr)
|
Lumen of seminiferous tubule
→ Transported to EPIDIDYMIS (maturation + storage)
→ VAS DEFERENS → EJACULATORY DUCT → URETHRA
| Function | Details |
|---|---|
| Nutritional support | Provide nutrients (lactate, pyruvate) to developing spermatogenic cells (which have no direct blood supply inside tubule) |
| Blood-testis barrier (BTB) | Tight junctions between adjacent Sertoli cells divide tubule into basal compartment (spermatogonia + preleptotene spermatocytes) and adluminal compartment (post-meiotic cells). Prevents immune attack on haploid spermatogenic cells (which express novel antigens) |
| Phagocytosis | Remove residual cytoplasm (residual bodies) and apoptotic cells |
| Inhibin B secretion | Inhibin B specifically inhibits FSH (negative feedback) |
| Androgen-binding protein (ABP) | Concentrates testosterone in seminiferous tubule (needed for spermatogenesis) |
| Anti-Müllerian hormone (AMH) | In fetal life → causes regression of Müllerian ducts (which would otherwise become uterus/fallopian tubes) |
| Oestrogen synthesis | Convert androgens to oestrogens via aromatase |
| FSH receptor | FSH acts on Sertoli cells (not on germ cells directly) |
HYPOTHALAMUS → GnRH (pulsatile)
↓
ANTERIOR PITUITARY
↓ FSH ↓ LH
Sertoli cells Leydig cells
→ Spermatogenesis → Testosterone
→ Inhibin B (→ ↓ FSH) ← LH (negative feedback via testosterone)
→ ABP (concentrates T)
↓
TESTOSTERONE
→ Spermatogenesis (final steps, esp. spermiogenesis)
→ Secondary sexual characters
→ Negative feedback on LH (at both hypothalamus + pituitary)
→ Inhibit FSH (partially)
HEAD (5 µm long):
┌──────────────────┐
│ ACROSOME cap │ ← Hyaluronidase, acrosin
│ ───────────── │ (penetrates zona pellucida)
│ NUCLEUS │ ← Haploid (23 chr); condensed
└──────────────────┘
NECK (short connecting piece)
├── Centriole (proximal)
MID-PIECE (5 µm):
├── Mitochondria (helix around axoneme) ← ATP generation
└── 9+2 axoneme begins
PRINCIPAL PIECE (45 µm - longest):
└── 9+2 microtubule axoneme
└── Fibrous sheath (stiffness)
END PIECE (5 µm, bare axoneme)
| Feature | Spermatogenesis | Oogenesis |
|---|---|---|
| Starts | Puberty | Fetal life (5th month in utero) |
| Continuous? | Continuous from puberty → death | Arrested: meiosis I (birth) → meiosis II (only at fertilization) |
| Products per meiosis | 4 equal spermatids | 1 secondary oocyte + 3 polar bodies (unequal division - cytoplasm retained in egg) |
| Duration | ~74 days | Months to decades (follicular phase each cycle) |
| Location | Seminiferous tubules | Ovarian follicle |
| Number | Millions per day | 1 per month (usually) |
| Temperature | 34-35°C (lower than body temp) | 37°C (inside body) |
| Arrest points | No arrest (continuous process) | Meiosis I (at birth), Meiosis II (at ovulation, completed only if fertilized) |
| Final stage | Spermatozoon (free, motile) | Secondary oocyte (completes meiosis II only if sperm penetrates) |
| Q | Answer | Key Point |
|---|---|---|
| 1. LH surge in the menstrual cycle occurs on: | Day 12-14 (before Day 14 ovulation) | Triggered by positive feedback of high E₂ |
| 2. Duration of luteal phase is: | Always ~14 days (constant) | Follicular phase varies; luteal phase is fixed |
| 3. Corpus luteum is rescued by: | hCG (from trophoblast) | Mimics LH; basis of pregnancy test |
| 4. Number of spermatids produced from 1 primary spermatocyte: | 4 | 1 → 2 (meiosis I) → 4 (meiosis II) |
| 5. Spermatogenesis requires temperature of: | 34-35°C (2-3°C below body temp) | Cryptorchidism causes infertility |
| 6. Inhibin B selectively inhibits: | FSH (not LH) | From Sertoli cells |
| 7. Anti-Müllerian hormone (AMH) is produced by: | Sertoli cells | Causes Müllerian duct regression in male fetus |
| 8. Progesterone is thermogenic - BBT rises by: | 0.2-0.5°C post-ovulation | Confirms ovulation occurred |
| 9. Acrosome is derived from: | Golgi apparatus | Contains enzymes for zona pellucida penetration |
| 10. Cervical mucus is thinnest (ferning) in: | Mid-cycle (oestrogen peak) | Facilitates sperm penetration; progesterone makes it thick |
| # | Topic | Status |
|---|---|---|
| 1-11 | CVS, Respiratory, Environmental, Endocrine | ✅ |
| 12 | Menstrual Cycle + Spermatogenesis | ✅ Done |
| → 13 | GIT: Deglutition + Gastric Juice + Intestinal Movements | Next |
| 14 | Bilirubin + Jaundice | Pending |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
| 17 | Pituitary + Calcium + Aldosterone | Pending |
| 18 | AETCOM | Pending |
Next
Deglutition is the complex neuromuscular act of propelling a bolus of food from the mouth to the stomach. It involves coordinated activity of 26 muscle pairs and 5 cranial nerves.
ORAL PHASE: Tongue → pushes bolus back → fauces stimulated
PHARYNGEAL PHASE:
Soft palate ↑ (seals nasopharynx)
Epiglottis folds back ← Larynx ↑
Vocal cords close (glottis sealed)
UOS relaxes ↓
Pharyngeal peristalsis →→→ OESOPHAGUS
OESOPHAGEAL PHASE:
←──── Primary peristalsis travels down ────→
[Upper 1/3: striated] [Lower 2/3: smooth]
LOS relaxes when bolus approaches → bolus enters STOMACH
| Cell Type | Location | Secretion | Function |
|---|---|---|---|
| Mucous neck cells | Neck of glands | Mucus (soluble) | Lubrication |
| Surface mucous cells | Surface of mucosa | Mucus (gel) + HCO₃⁻ | Gastric mucosal barrier |
| Chief cells (peptic cells) | Base of glands | Pepsinogen | Precursor of pepsin |
| Parietal cells (oxyntic cells) | Mid-gland | HCl + Intrinsic factor (IF) | Digestion + B12 absorption |
| G cells | Antrum (not fundal glands) | Gastrin | Stimulates HCl + pepsinogen |
| D cells | Antrum + body | Somatostatin | Inhibits gastrin + HCl |
| ECL cells (Enterochromaffin-like) | Body/fundus | Histamine | Paracrine stimulator of parietal cells |
Inside parietal cell:
CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻
(carbonic anhydrase)
↓
H⁺ pumped INTO lumen via H⁺/K⁺-ATPase (proton pump)
[exchanges H⁺ for K⁺; K⁺ enters cell then leaks back to lumen]
HCO₃⁻ exits to blood via Cl⁻/HCO₃⁻ exchanger on basolateral side
[Cl⁻ enters cell → secreted into lumen via apical Cl⁻ channel]
Net: HCl secreted into lumen; HCO₃⁻ into blood
(This HCO₃⁻ surge into blood = "alkaline tide" after a meal)
| Phase | Stimulus | Mechanism | Acid secreted |
|---|---|---|---|
| Cephalic phase | Sight, smell, taste, thought of food | Vagus nerve → ACh → parietal cells + G cells | ~20-30% |
| Gastric phase | Food in stomach; gastric distension; amino acids/peptides | Vagal reflexes + Gastrin (from G cells) + Histamine (from ECL cells) | ~60-70% (largest) |
| Intestinal phase | Food enters duodenum | Duodenal gastrin (small); negative feedback begins | ~5-10% |
| Stimulus | Mechanism | Result |
|---|---|---|
| ↓ Antral pH (< 2.5) | Somatostatin from D cells → inhibits G cells and parietal cells | ↓ Gastrin, ↓ HCl (feedback) |
| Fat in duodenum | Secretin, CCK, GIP (enterogastrones) | ↓ Gastric emptying, ↓ HCl |
| Acid in duodenum | Secretin → ↑ HCO₃⁻ (from pancreas), ↓ gastrin | Neutralizes duodenal acid |
| Distension of duodenum | Enterogastric reflex (nervous) | ↓ Gastric motility + secretion |
| Hormone | Source | Stimulus | Actions |
|---|---|---|---|
| Gastrin | G cells (antrum) | Amino acids, peptides, vagal stimulation, gastric distension | ↑ HCl, ↑ Pepsinogen, ↑ mucosal growth, ↑ gastric motility |
| Secretin | S cells (duodenum) | Acid in duodenum (pH < 4.5) | ↑ Pancreatic HCO₃⁻, ↓ Gastrin, ↓ HCl, ↑ bile flow |
| CCK (Cholecystokinin) | I cells (duodenum) | Fat + protein in duodenum | ↑ Pancreatic enzymes, ↑ bile secretion (gallbladder contracts), ↓ gastric emptying, satiety |
| GIP (Glucose-dependent insulinotropic peptide) | K cells (duodenum) | Glucose + fat | ↑ Insulin secretion (incretin), ↓ HCl |
| GLP-1 | L cells (ileum/colon) | Fat + carbohydrate | ↑ Insulin (incretin), ↓ glucagon, ↓ gastric emptying, satiety |
| Motilin | Mo cells (duodenum/jejunum) | Fasting state (every 90 min) | ↑ MMC (interdigestive contractions) |
| VIP | Myenteric neurons | Neural | Intestinal relaxation, ↑ water + electrolyte secretion |
| Somatostatin | D cells (stomach, pancreas) | Acid, fat, protein | Inhibits all GIT secretion + motility (universal inhibitor) |
| Q | Answer | Key Point |
|---|---|---|
| 1. Only voluntary phase of deglutition: | Oral phase | Pharyngeal + oesophageal are reflexes |
| 2. Swallowing centre is located in: | Medulla oblongata | NTS + nucleus ambiguus |
| 3. Intrinsic factor is secreted by: | Parietal cells | Same cell as HCl |
| 4. Chief cells secrete: | Pepsinogen | Activated to pepsin by HCl at pH <5 |
| 5. Gastrin is secreted by: | G cells in antrum | Stimulated by AA, peptides, vagus |
| 6. Secretin is released by: | Acid in duodenum (pH <4.5) | Stimulates pancreatic HCO₃⁻ |
| 7. Main movement for absorption in small intestine: | Segmentation | Mixing movement; not peristalsis |
| 8. MMC is controlled by: | Motilin | Every 90 min in fasting state |
| 9. Fat is absorbed via: | Lacteals (lymphatics) → thoracic duct | Not portal vein (unlike amino acids + glucose) |
| 10. PPIs act on: | H⁺/K⁺-ATPase (proton pump) | Final common pathway; most potent acid suppression |
| # | Topic | Status |
|---|---|---|
| 1-12 | CVS, Respiratory, Environmental, Endocrine, Reproductive | ✅ |
| 13 | GIT: Deglutition + Gastric Juice + Intestinal Movements | ✅ Done |
| → 14 | Bilirubin Metabolism + Jaundice | Next |
| 15 | Temperature Regulation | Pending |
| 16 | Exercise Physiology | Pending |
| 17 | Pituitary + Calcium + Aldosterone | Pending |
| 18 | AETCOM | Pending |